| Luciferase activity (AU) |
|---|
| 104 |
| 108 |
| 64 |
| 28 |
| 100 |
| 152 |
| 176 |
| 52 |
| 124 |
| 44 |
| 60 |
| 60 |
| 32 |
| 96 |
| 60 |
| 144 |
| 28 |
| 64 |
| 84 |
| 44 |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Binding energy | = | 13.1 | kCal mol-1 |
| Binding energy | = | 11.2 | kCal mol-1 |
| Binding energy | = | 7.9 | kCal mol-1 |
| Binding energy | = | 6.8 | kCal mol-1 |
| Binding energy | = | 12.5 | kCal mol-1 |
| Binding energy | = | 12.7 | kCal mol-1 |
| Binding energy | = | 11.5 | kCal mol-1 |
| Binding energy | = | 12.9 | kCal mol-1 |
| Binding energy | = | 10.7 | kCal mol-1 |
| Binding energy | = | 11.2 | kCal mol-1 |
| Binding energy | = | 7.2 | kCal mol-1 |
| Binding energy | = | 12.3 | kCal mol-1 |
| Binding energy | = | 11.5 | kCal mol-1 |
| Binding energy | = | 12.8 | kCal mol-1 |
| Binding energy | = | 11.7 | kCal mol-1 |
| Binding energy | = | 9.7 | kCal mol-1 |
| Binding energy | = | 8.9 | kCal mol-1 |
| Binding energy | = | 12.3 | kCal mol-1 |
| Binding energy | = | 6.8 | kCal mol-1 |
| Binding energy | = | 12.8 | kCal mol-1 |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000295000 uM | Activity at 0.0000590000 uM | Activity at 0.0001503265 uM | Activity at 0.0002712146 uM | Activity at 0.0005895491 uM | Activity at 0.00117 uM | Activity at 0.00179 uM | Activity at 0.00299 uM | Activity at 0.00672 uM | Activity at 0.014 uM | Activity at 0.026 uM | Activity at 0.040 uM | Activity at 0.074 uM | Activity at 0.167 uM | Activity at 0.363 uM | Activity at 0.628 uM | Activity at 0.975 uM | Activity at 1.849 uM | Activity at 4.119 uM | Activity at 9.037 uM | Activity at 15.83 uM | Activity at 21.08 uM | Activity at 46.23 uM | Activity at 92.54 uM | Activity at 165.6 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 4 | -3.0662 | -2.4126 | 1.9741 | -4.0617 | -0.6298 | -3.0662 | QC'd by "Chem Div" | ||||||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.7346 | -0.808 | -4.308 | 4 | 0 0 0 0 0 | -0.431 | -4.308 | 0.8987 | -1.5892 | -1.522 | -0.431 | QC'd by "Chem Div" | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.6448 | -12.5127 | 4.5585 | 4 | 0 0 0 0 0 | -9.7509 | 6.5585 | 1.6006 | -0.8104 | 11.697 | -9.7509 | QC'd by "Chem Div" | |||||||||||||||||||||||||
| Inhibitor | 18.3564 | 99.0378 | 41 | Partial curve; high efficacy | -4.7362 | 2.8473 | 0.9985 | -99.5803 | -0.5425 | -2.1 | 0 0 0 0 0 | -92.8278 | -1.5772 | -1.9365 | 1.8258 | -13.1847 | -92.8278 | QC'd by "Chem Div" | |||||||||||||||||||||
| Inhibitor | 29.0929 | 42.1815 | 10 | Single point of activity | -4.5362 | 4.9549 | 0.9879 | -50.8391 | -8.6577 | -3 | 0 0 0 0 0 | -46.8496 | -7.6387 | -8.6142 | -11.6103 | -6.66 | -46.8496 | QC'd by "Chem Div" | |||||||||||||||||||||
| Inhibitor | 18.3564 | 123.8718 | 41 | Partial curve; high efficacy | -4.7362 | 1.6259 | 0.9975 | -121.4578 | 2.414 | -2.1 | 0 0 0 0 0 | -98.8224 | 5.0098 | -1.1767 | -0.5372 | -27.2941 | -98.8224 | QC'd by "Chem Div" | |||||||||||||||||||||
| Inhibitor | 14.581 | 109.9073 | 42 | Partial curve; high efficacy | -4.8362 | 1.8265 | 0.9637 | -106.4086 | 3.4987 | -2.1 | 0 0 0 0 0 | -94.6709 | 12.0352 | -9.7094 | 6.0901 | -28.9742 | -94.6709 | QC'd by "Chem Div" | |||||||||||||||||||||
| Inactive | 0 | 0.3 | 0.9096 | -34.0578 | -3.7697 | 4 | 0 0 0 0 0 | -28.0098 | -7.7697 | -15.2699 | -21.1534 | -19.3019 | -28.0098 | QC'd by "Chem Div" | |||||||||||||||||||||||||
| Inhibitor | 29.0929 | 90.8978 | 10 | Single point of activity | -4.5362 | 4.4495 | 0.9936 | -90.3368 | 0.561 | -3 | 0 0 0 0 0 | -79.9635 | 5.0637 | -2.1732 | -1.6903 | 0.5114 | -79.9635 | QC'd by "Chem Div" | |||||||||||||||||||||
| Inactive | 0 | 0.3 | 0.4266 | 15.2787 | -6.7213 | 4 | 0 0 0 0 0 | 10.4803 | -5.7213 | 8.5589 | -5.3046 | 6.719 | 10.4803 | QC'd by "Chem Div" | |||||||||||||||||||||||||
| Inactive | 0 | 1.9673 | 0.6089 | -9.5082 | 5.2968 | 4 | 0 0 0 0 0 | -7.9574 | 7.2968 | -1.8903 | 10.3946 | 1.3036 | -7.9574 | QC'd by "Chem Div" | |||||||||||||||||||||||||
| Inhibitor | 16.3601 | 45.5047 | 10 | Single point of activity | -4.7862 | 4.9549 | 0.9618 | -49.1256 | -3.6209 | -3 | 0 0 0 0 0 | -48.9315 | -7.5358 | -6.333 | 2.7698 | -6.0371 | -48.9315 | QC'd by "Chem Div" | |||||||||||||||||||||
| Inactive | 0 | -5.2862 | 0.8 | 0.9747 | -26.7427 | 8.4372 | 4 | 0 0 0 0 0 | -20.7127 | 9.4372 | 2.2965 | 0.248 | -14.6534 | -20.7127 | QC'd by "Chem Div" | ||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.9526 | -10.3928 | 12.1594 | 4 | 0 0 0 0 0 | -10.3008 | 7.6594 | 13.8067 | 14.3816 | -9.7278 | -10.3008 | QC'd by "Chem Div" | |||||||||||||||||||||||||
| Inactive | 0 | 2.2526 | 0.9456 | -15.0824 | -3.8247 | 4 | 0 0 0 0 0 | -14.7061 | -2.8247 | -5.6912 | -3.1226 | -9.4063 | -14.7061 | QC'd by "Chem Div" | |||||||||||||||||||||||||
| Inhibitor | 12.9953 | 78.8447 | 42 | Partial curve; high efficacy | -4.8862 | 1.5579 | 0.9935 | -82.5518 | -3.7072 | -2.1 | 0 0 0 0 0 | -72.8175 | -6.4603 | -0.3489 | -8.7793 | -32.8366 | -72.8175 | QC'd by "Chem Div" | |||||||||||||||||||||
| Inhibitor | 18.3564 | 49.7424 | 10 | Single point of activity | -4.7362 | 2.8473 | 0.9797 | -46.1416 | 3.6008 | -3 | 0 0 0 0 0 | -42.7679 | -0.8992 | 4.983 | 6.9739 | -2.5062 | -42.7679 | QC'd by "Chem Div" | |||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.8308 | -9.799 | 10.4725 | 4 | 0 0 0 0 0 | -5.0871 | 8.4725 | 8.2561 | 10.0709 | 16.081 | -5.0871 | QC'd by "Chem Div" | |||||||||||||||||||||||||
| Inactive | 0 | 1.8851 | 0.9722 | -5.7685 | 6.2205 | 4 | 0 0 0 0 0 | -5.063 | 6.2205 | -1.5445 | -7.1037 | -5.5678 | -5.063 | QC'd by "Chem Div" | |||||||||||||||||||||||||
| Inactive | 0 | 0.3 | 0.842 | -31.9249 | 3.174 | 4 | 0 0 0 0 0 | -26.7418 | -0.826 | -13.6909 | -13.1344 | -14.0869 | -26.7418 | QC'd by "Chem Div" |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000295000 uM | Activity at 0.0000590000 uM | Activity at 0.0001503265 uM | Activity at 0.0002712146 uM | Activity at 0.0005895491 uM | Activity at 0.00117 uM | Activity at 0.00179 uM | Activity at 0.00299 uM | Activity at 0.00672 uM | Activity at 0.014 uM | Activity at 0.026 uM | Activity at 0.040 uM | Activity at 0.074 uM | Activity at 0.167 uM | Activity at 0.363 uM | Activity at 0.628 uM | Activity at 0.975 uM | Activity at 1.849 uM | Activity at 4.119 uM | Activity at 9.037 uM | Activity at 15.83 uM | Activity at 21.08 uM | Activity at 46.23 uM | Activity at 92.54 uM | Activity at 165.6 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 20.5962 | 118.891 | 41 | Partial curve; high efficacy | -4.6862 | 2.3031 | 0.9994 | -116.1669 | 2.7241 | -2.1 | 0 0 0 0 0 | -99.9451 | 2.7241 | 4.2572 | 0.7717 | -13.7373 | -99.9451 | QC'd by "Asinex Ltd." | |||||||||||||||||||||
| Inactive | 0 | 0.8 | 0.9749 | -16.1771 | 2.0057 | 4 | 0 0 0 0 0 | -13.1466 | 2.0057 | 1.2486 | -2.8352 | -5.7162 | -13.1466 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.6148 | -11.801 | 2.2059 | 4 | 0 0 0 0 0 | -9.7999 | -4.7941 | 3.6452 | 6.7363 | 3.1419 | -9.7999 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||
| Inactive | 0 | -5.0362 | 2.3332 | 0.9795 | -28.8852 | -5.2723 | 4 | 0 0 0 0 0 | -28.1997 | -7.2723 | -3.3531 | -4.7215 | -17.5124 | -28.1997 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||
| Inhibitor | 5.1735 | 94.6885 | 84 | Complete curve; high efficacy | -5.2862 | 2.9023 | 0.9917 | -96.1842 | -1.4957 | -1.1 | 0 0 0 0 0 | -96.0073 | -7.5308 | 4.5779 | -6.8491 | -81.1577 | -96.0073 | QC'd by "Asinex Ltd." | |||||||||||||||||||||
| Inhibitor | 18.3564 | 94.012 | 10 | Single point of activity | -4.7362 | 3.6272 | 0.9999 | -96.5346 | -2.5226 | -3 | 0 0 0 0 0 | -93.107 | -2.9055 | -1.9361 | -2.363 | -9.7613 | -93.107 | QC'd by "Asinex Ltd." | |||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.8434 | -31.3086 | -2.255 | 4 | 0 0 0 0 0 | -27.0497 | -0.755 | -10.521 | 0.9228 | 0.8125 | -27.0497 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||
| Inactive | 0 | 4.4495 | 0.7303 | -25.728 | -7.2492 | 4 | 0 0 0 0 0 | -25.3982 | -8.7492 | -13.5128 | 0.9177 | -19.0413 | -25.3982 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||
| Inhibitor | 20.5962 | 100.5411 | 41 | Partial curve; high efficacy | -4.6862 | 2.0937 | 0.998 | -104.3872 | -3.8461 | -2.1 | 0 0 0 0 0 | -88.9539 | -4.1551 | -2.0443 | -7.1093 | -18.8654 | -88.9539 | QC'd by "Asinex Ltd." | |||||||||||||||||||||
| Inhibitor | 29.0929 | 91.4133 | 10 | Single point of activity | -4.5362 | 4.9549 | 0.9947 | -88.3597 | 3.0536 | -3 | 0 0 0 0 0 | -79.845 | -1.1685 | 2.6559 | 4.5385 | 5.7131 | -79.845 | QC'd by "Asinex Ltd." | |||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.786 | -1.8499 | 12.9954 | 4 | 0 0 0 0 1 | 16.1947 | 7.9954 | 18.2295 | 0.5262 | -1.8757 | 16.1947 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.9259 | -4.5454 | 4.3839 | 4 | 0 0 0 0 0 | -3.7239 | 5.3839 | 4.747 | 2.666 | 4.8335 | -3.7239 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||
| Inactive | 0 | -6.2362 | 4.9549 | 0.9762 | -1.4086 | 19.4543 | 4 | 0 0 0 0 0 | 1.2086 | 19.4543 | 17.7088 | -3.3481 | -2.3756 | 1.2086 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.4363 | -4.5616 | -11.5616 | 4 | 0 0 0 0 0 | -4.5336 | -11.5616 | -1.6565 | -10.5162 | -2.2482 | -4.5336 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||
| Inactive | 0 | 0.7 | 0.9889 | 6.5184 | -6.9816 | 4 | 0 0 0 0 0 | 2.8921 | -7.4816 | -5.7762 | -3.9537 | -1.5242 | 2.8921 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.5926 | -22.1394 | -0.1559 | 4 | 0 0 0 0 0 | -20.8088 | -4.1559 | -8.304 | 12.2914 | -0.0696 | -20.8088 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||
| Inhibitor | 29.0929 | 64.2186 | 10 | Single point of activity | -4.5362 | 4.9549 | 0.9684 | -70.1227 | -5.9041 | -3 | 0 0 0 0 0 | -64.396 | -9.2052 | -0.418 | -11.9994 | -2.9068 | -64.396 | QC'd by "Asinex Ltd." | |||||||||||||||||||||
| Inactive | 0 | 1.21 | 0.9644 | -26.9263 | 4.8437 | 4 | 0 0 0 0 0 | -17.9647 | 6.8437 | 4.9663 | 0.5719 | -1.9517 | -17.9647 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.9261 | -29.987 | 1.9364 | 4 | 0 0 0 0 0 | -26.9998 | 0.4364 | -0.7582 | -0.4532 | 7.9656 | -26.9998 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||
| Inactive | 0 | 4.095 | 0.4576 | 1.7803 | 12.607 | 4 | 0 0 0 0 0 | 6.6132 | 11.107 | -4.9986 | 0.186 | 5.2579 | 6.6132 | QC'd by "Asinex Ltd." |
| OD | %Activity | 384ID |
|---|---|---|
| 1.054 | 109.579307687748 | 5A04 |
| 1.048 | 108.512388121629 | 5A05 |
| 1.085 | 115.091725446032 | 5A06 |
| 1.154 | 127.361300456404 | 5A07 |
| 1.12 | 121.315422915061 | 5A08 |
| 1.115 | 120.426323276629 | 5A09 |
| 1.126 | 122.382342481181 | 5A11 |
| 1.154 | 127.361300456404 | 5A12 |
| 1.138 | 124.516181613419 | 5A13 |
| 1.17 | 130.206419299389 | 5A14 |
| 1.155 | 127.539120384091 | 5A16 |
| 1.128 | 122.737982336554 | 5A17 |
| 1.156 | 127.716940311778 | 5A18 |
| 1.053 | 109.401487760062 | 5A19 |
| 1.052 | 109.223667832375 | 5A20 |
| 1.067 | 111.890966747673 | 5A21 |
| 1.032 | 105.667269278644 | 5A22 |
| 1.062 | 111.001867109241 | 5B03 |
| 1.091 | 116.158645012151 | 5B06 |
| 1.108 | 119.181583782823 | 5B08 |
| orf | sym | raw OD read 1 | raw OD read 2 | normalized OD average | z_score | p_value | non replicate | cryptagen | bioactivity |
|---|---|---|---|---|---|---|---|---|---|
| YMR263W | SAP30 | 0.8109 | 0.8241 | 1.00792 | 0.676525 | 0.251267 | 0 | 0 | |
| YMR263W | SAP30 | 0.7074 | 0.7045 | 0.999472 | -0.0270066 | 0.438533 | 0 | 0 | |
| YMR263W | SAP30 | 0.7132 | 0.8281 | 1.01796 | 0.622507 | 0.272346 | 0 | 1 | |
| YMR263W | SAP30 | 0.8097 | 0.7087 | 1.00875 | 0.761485 | 0.226416 | 0 | 0 | |
| YMR263W | SAP30 | 0.6981 | 0.8259 | 1.0105 | 0.374462 | 0.354279 | 0 | 0 | |
| YMR263W | SAP30 | 0.8085 | 0.7063 | 1.00502 | 0.437036 | 0.331931 | 0 | 0 | |
| YMR263W | SAP30 | 0.6535 | 0.6897 | 0.990762 | -0.328328 | 0.371394 | 0 | 0 | |
| YMR263W | SAP30 | 0.8133 | 0.6941 | 1.00717 | 0.598889 | 0.290952 | 0 | 0 | |
| YMR263W | SAP30 | 0.6867 | 0.8019 | 0.976773 | -0.824746 | 0.205247 | 0 | 0 | |
| YMR263W | SAP30 | 0.7836 | 0.6862 | 0.991018 | -0.771634 | 0.220389 | 0 | 0 | |
| YMR263W | SAP30 | 0.5995 | 0.6139 | 0.893377 | -3.80387 | 0.000378032 | 0 | 1 | |
| YMR263W | SAP30 | 0.6271 | 0.8094 | 0.962532 | -1.30683 | 0.107741 | 0 | 0 | |
| YMR263W | SAP30 | 0.6878 | 0.6957 | 0.980366 | -0.684868 | 0.249934 | 0 | 0 | |
| YMR263W | SAP30 | 0.6868 | 0.6962 | 0.978746 | -0.741689 | 0.232811 | 0 | 0 | |
| YMR263W | SAP30 | 0.6541 | 0.6484 | 0.937529 | -2.23241 | 0.020073 | 0 | 1 | |
| YMR263W | SAP30 | 0.8121 | 0.8259 | 1.00972 | 0.830941 | 0.205153 | 0 | 0 | |
| YMR263W | SAP30 | 0.6816 | 0.6968 | 1.00208 | 0.0681669 | 0.45957 | 0 | 0 | |
| YMR263W | SAP30 | 0.7058 | 0.7983 | 0.990309 | -0.360795 | 0.366558 | 0 | 0 | |
| YMR263W | SAP30 | 0.7873 | 0.8034 | 0.980792 | -1.66055 | 0.0499532 | 0 | 0 | |
| YMR263W | SAP30 | 0.6917 | 0.7012 | 0.997639 | -0.0875704 | 0.465208 | 0 | 1 |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000000311 uM | Activity at 0.0000000880 uM | Activity at 0.0000001756 uM | Activity at 0.0000004972 uM | Activity at 0.0000014063 uM | Activity at 0.0000028127 uM | Activity at 0.0000079555 uM | Activity at 0.0000225014 uM | Activity at 0.0000450029 uM | Activity at 0.0001299230 uM | Activity at 0.0003002708 uM | Activity at 0.0008965874 uM | Activity at 0.00268 uM | Activity at 0.00700 uM | Activity at 0.016 uM | Activity at 0.032 uM | Activity at 0.076 uM | Activity at 0.219 uM | Activity at 0.631 uM | Activity at 1.728 uM | Activity at 3.886 uM | Activity at 8.589 uM | Activity at 17.80 uM | Activity at 49.20 uM | Activity at 107.3 uM | Activity at 231.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 4.9549 | 0.4153 | -14.5146 | 1 | 4 | 0 0 0 0 1 | 4.685 | -8.5335 | 0.7807 | 11.3474 | -12.5122 | 4.685 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Activator | 12.5893 | 29.2705 | 0 | Single point of activity | -4.9 | 4.9549 | 0.9612 | 31 | 1.7295 | 3 | 0 0 0 0 0 | 30.9001 | -1.4754 | 1.0166 | 5.6243 | 6.6083 | 30.9001 | QC'd by "Microsource" | ||||||||||||||||||||||
| Activator | 8.9125 | 65.9699 | 0 | Partial curve; partial efficacy | -5.05 | 0.6 | 0.9478 | 60.7629 | -5.207 | 2.2 | 0 0 0 0 0 | 46.0767 | -2.3225 | 0.7459 | 18.7564 | 22.5194 | 46.0767 | QC'd by "Microsource" | ||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.3508 | -5.4241 | 12 | 4 | 0 0 0 0 0 | 2.824 | 6.9985 | -6.3081 | -17.4367 | -1.0266 | 2.824 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Inactive | 0 | 4.095 | 0.8518 | -20.6942 | -4.8432 | 4 | 1 0 0 0 0 | -16.9639 | -25.916 | -5.286 | -19.6983 | -24.7451 | -16.9639 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.8518 | -16.2964 | 1.5 | 4 | 0 0 0 0 1 | 4.1206 | 1.8961 | -0.6171 | -21.497 | -11.4248 | 4.1206 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Activator | 2.2387 | 83.6659 | 0 | Partial curve; partial efficacy; poor fit | -5.65 | 0.5 | 0.8806 | 54.0974 | -29.5685 | 2.4 | 0 0 0 0 0 | 44.3794 | -19.3312 | -4.1329 | 18.8496 | 13.5792 | 44.3794 | QC'd by "Microsource" | ||||||||||||||||||||||
| Inhibitor | 12.5893 | 81.1747 | 42 | Partial curve; high efficacy | -4.9 | 4.095 | 0.9407 | -88.2352 | -7.0605 | -2.1 | 0 0 0 0 0 | -88.059 | -2.1141 | 2.5457 | -21.0606 | -24.383 | -88.059 | QC'd by "Microsource" | ||||||||||||||||||||||
| Inactive | 0 | 0.8 | 0.9754 | 0.5 | 18 | 4 | 0 0 0 0 0 | 0.1686 | 15.5939 | 9.5523 | 5.2389 | 3.3969 | 0.1686 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.516 | 14 | -11.1922 | 4 | 0 0 0 0 0 | 8.9233 | 2.0681 | -9.5798 | -21.4101 | -15.067 | 8.9233 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Inhibitor | 10 | 111.4578 | 10 | Partial curve; high efficacy; poor fit | -5 | 4.095 | 0.8557 | -88.0204 | 23.4373 | -2.3 | 0 0 0 0 0 | -86.963 | 0.1371 | 16.1149 | 55.0816 | -24.8092 | -86.963 | QC'd by "Microsource" | ||||||||||||||||||||||
| Inhibitor | 12.5893 | 111.8609 | 10 | Single point of activity | -4.9 | 1.3987 | 0.9539 | -66.6934 | 45.1675 | -3 | 0 0 0 0 0 | -51.9056 | 34.8895 | 58.2591 | 32.624 | 3.3045 | -51.9056 | QC'd by "Microsource" | ||||||||||||||||||||||
| Inactive | 0 | 4 | 9.4501 | 23.4721 | 50.1914 | -0.8776 | 27.4967 | 9.4501 | QC'd by "Microsource" | |||||||||||||||||||||||||||||||
| Inactive | 0 | 3.6272 | 0.9908 | -9.6077 | 22.5 | 4 | 0 0 0 0 0 | -9.2564 | 21.9907 | 20.6042 | 24.2232 | 8.6092 | -9.2564 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Activator | 0 | Single point of activity | 4.9549 | 0.3547 | 25.2512 | 5 | 3 | 0 0 0 0 1 | 15.4142 | 5.7176 | 6.5342 | 43.2316 | 7.0919 | 15.4142 | QC'd by "Microsource" | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.6074 | 7 | 18.5 | 4 | 0 0 0 0 0 | 11.6515 | 12.5897 | 21.5938 | 21.2209 | 4.3118 | 11.6515 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Activator | 2.2387 | 52.7895 | 0 | Partial curve; partial efficacy | -5.65 | 2.2526 | 0.9613 | 44.2358 | -8.5537 | 2.2 | 0 0 0 0 1 | -9.4264 | -2.4981 | -13.182 | 11.9591 | 42.1127 | -9.4264 | QC'd by "Microsource" | ||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.942 | 28 | 1.1909 | 4 | 0 0 0 0 1 | 1.5316 | 4.6729 | 1.2372 | -2.341 | 24.4478 | 1.5316 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Inhibitor | 35.4813 | 55.7622 | 10 | Single point of activity | -4.45 | 4.9549 | 0.7876 | -42.7915 | 12.9707 | -3 | 0 0 0 0 0 | -30.6839 | 14.5151 | 3.8713 | 4.7738 | 29.0235 | -30.6839 | QC'd by "Microsource" | ||||||||||||||||||||||
| Inhibitor | 35.4813 | 49.2317 | 10 | Single point of activity | -4.45 | 4.4495 | 0.7066 | -51.9324 | -2.7008 | -3 | 0 0 0 0 0 | -40.193 | -17.9891 | 11.8148 | -5.5992 | 0.7455 | -40.193 | QC'd by "Microsource" |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000000311 uM | Activity at 0.0000000880 uM | Activity at 0.0000001756 uM | Activity at 0.0000004972 uM | Activity at 0.0000014063 uM | Activity at 0.0000028127 uM | Activity at 0.0000079555 uM | Activity at 0.0000225014 uM | Activity at 0.0000450029 uM | Activity at 0.0001299230 uM | Activity at 0.0003002708 uM | Activity at 0.0008965874 uM | Activity at 0.00268 uM | Activity at 0.00700 uM | Activity at 0.016 uM | Activity at 0.032 uM | Activity at 0.076 uM | Activity at 0.219 uM | Activity at 0.631 uM | Activity at 1.728 uM | Activity at 3.886 uM | Activity at 8.587 uM | Activity at 17.80 uM | Activity at 49.20 uM | Activity at 107.3 uM | Activity at 231.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 25.1189 | 46.3945 | 20 | Partial curve; partial efficacy | -4.6 | 2.2526 | 0.9287 | -51.2557 | -4.8612 | -2.2 | 0 0 0 0 0 | -41.1028 | -5.7868 | -8.9838 | -1.9677 | -26.4188 | -41.1028 | QC'd by "BIOMOL" | ||||||||||||||||||||||
| Inactive | 0 | 3.5117 | 0.9435 | 10 | -4.567 | 4 | 0 0 0 0 1 | -5.6299 | -3.6518 | -3.5753 | -4.2225 | 6.795 | -5.6299 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inactive | 0 | 3.0654 | 0.9376 | 11 | -2.7695 | 4 | 0 0 0 0 1 | -2.8045 | -1.4193 | -3.1412 | -1.9048 | 7.584 | -2.8045 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.7625 | 1 | -16.7 | 4 | 0 0 0 0 | -0.288 | -12.25 | 5.019 | -2.495 | -0.288 | QC'd by "Prestwick Chemical; Inc." | |||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.8335 | 4.5 | -7.0946 | 4 | 0 0 0 0 | 3.0138 | -4.2455 | 6.6652 | 3.4342 | 3.0138 | QC'd by "Prestwick Chemical; Inc." | |||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.993 | 0.5 | -16.2895 | 4 | 0 0 0 0 1 | -17.2531 | -11.9079 | 0.4577 | 0.7459 | 0.1472 | -17.2531 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inactive | 0 | 3.0654 | 0.989 | -13.9862 | -8.1964 | 4 | 0 0 0 0 | -13.7385 | -8.6044 | -8.0804 | -9.4725 | -13.7385 | QC'd by "Prestwick Chemical; Inc." | |||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.8435 | -11.2843 | 4 | 4 | 0 0 0 0 0 | -11.9036 | 3.4878 | 5.2393 | 0.5291 | 5.9839 | -11.9036 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inactive | 0 | 0.8 | 0.7241 | 0.6 | -14.6999 | 4 | 0 0 0 0 1 | -12.1307 | -11.4165 | -6.1179 | -8.0206 | -2.8333 | -12.1307 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.8652 | 1 | -19.7041 | 4 | 0 0 0 0 0 | -4.2947 | -18.0867 | -15.9371 | 4.8395 | 2.1157 | -4.2947 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inhibitor | 14.1254 | 42.1465 | 10 | Single point of activity | -4.85 | 4.9549 | 0.8997 | -40.1465 | 2 | -3 | 0 0 0 0 0 | -41.8192 | -2.393 | 5.1804 | -2.5248 | 4.6867 | -41.8192 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.6566 | -10.2454 | 0 | 4 | 0 0 0 0 0 | -10.2045 | -4.5492 | -0.0989 | 4.6103 | -5.6017 | -10.2045 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.5279 | 3 | -11.3522 | 4 | 0 0 0 0 | 1.078 | -15.7102 | -2.9932 | -14.9547 | 1.078 | QC'd by "Prestwick Chemical; Inc." | |||||||||||||||||||||||||||
| Inactive | 0 | 1.6924 | 0.9123 | 0.5 | -10.147 | 4 | 0 0 0 0 | 0.4297 | -9.2892 | -3.9336 | -3.1566 | 0.4297 | QC'd by "Prestwick Chemical; Inc." | |||||||||||||||||||||||||||
| Inactive | 0 | 2.4064 | 0.7886 | 8 | -4.3029 | 4 | 0 0 0 0 0 | 5.7256 | -1.9822 | -4.4191 | -3.8175 | 8.0142 | 5.7256 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.997 | 5.5 | -12.076 | 4 | 0 0 0 1 | -6.5693 | -12.5633 | -7.4947 | 4.9219 | -6.5693 | QC'd by "Prestwick Chemical; Inc." | |||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.9232 | -18.4489 | -2.2837 | 4 | 0 0 0 0 | -16.2075 | -1.3456 | -4.9534 | -0.2364 | -16.2075 | QC'd by "Prestwick Chemical; Inc." | |||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.9481 | 2 | -17.5643 | 4 | 0 0 0 0 1 | -13.5121 | -12.9703 | 3.6247 | 1.4507 | 0.7522 | -13.5121 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.5725 | -10.2193 | 7.5 | 4 | 0 0 0 0 0 | -12.7555 | 5.891 | 7.5423 | -18.5161 | 0.6587 | -12.7555 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inhibitor | 31.6228 | 100.7069 | 40 | Partial curve; high efficacy | -4.5 | 3.5722 | 0.9933 | -104.0783 | -3.3715 | -2.1 | 0 0 0 0 0 | -83.3961 | 0.3188 | -7.6251 | -4.9588 | -20.5702 | -83.3961 | QC'd by "BIOMOL" |
| Phenotype | Potency | Efficacy | Analysis Comment | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.00366 uM | Activity at 0.018 uM | Activity at 0.023 uM | Activity at 0.046 uM | Activity at 0.073 uM | Activity at 0.091 uM | Activity at 0.165 uM | Activity at 0.229 uM | Activity at 0.457 uM | Activity at 0.575 uM | Activity at 0.940 uM | Activity at 1.600 uM | Activity at 2.289 uM | Activity at 3.140 uM | Activity at 4.699 uM | Activity at 9.139 uM | Activity at 11.40 uM | Activity at 21.25 uM | Activity at 28.60 uM | Activity at 57.07 uM | Activity at 80.69 uM | Activity at 114.0 uM | Activity at 162.0 uM | Activity at 229.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 4 | 5.7214 | 8.6314 | 10.1509 | 9.4532 | 6.7941 | 5.7214 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||||
| Inactive | 4 | 4.6112 | 4.6112 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||||||||
| Inactive | 4 | -2.3744 | -2.3744 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 0 | 6.7367 | -4.0062 | 2.2497 | 1.4266 | 2.0011 | 3.3808 | 6.7367 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||
| Inactive | 4 | -2.7854 | -1.3593 | -1.6912 | -2.0074 | 1.8167 | -0.4278 | -2.7854 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -2.7388 | 2.7691 | 0.219 | 4.542 | 3.4083 | -2.7388 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -0.0117 | 4.0579 | 0.9447 | 1.1341 | -2.3162 | -0.0117 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | 3.7695 | 11.7104 | 7.4353 | 4.0568 | 3.1008 | 3.7695 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||||||
| Inactive | 4 | 5.5498 | 5.9044 | 3.2491 | 5.276 | 6.9333 | 5.5498 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||||
| Inactive | 4 | 12.0843 | 12.9091 | 10.119 | 12.5774 | 12.2515 | 12.0843 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||||
| Inactive | 4 | -0.2629 | 2.9525 | 1.1464 | 1.4514 | 0.2181 | -0.2629 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||||
| Inactive | 4 | 8.3211 | 6.2941 | 7.289 | 4.2801 | 3.1894 | 8.3211 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||||
| Inactive | 4 | -3.1455 | -0.8453 | 2.5993 | -2.2393 | -0.3052 | -3.1455 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 1 | 3.7867 | 7.8704 | 5.3135 | 4.3995 | -2.7456 | 3.7867 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 1 | -8.8426 | -4.2899 | -7.4803 | -5.849 | -5.1242 | -0.9961 | -8.8426 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||
| Inactive | 4 | 3.1704 | 3.7523 | 0.2197 | 4.2066 | -1.7683 | 2.1784 | 3.1704 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||||||
| Inactive | 4 | 11.6449 | 11.6449 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||||||||
| Inactive | 4 | -0.8722 | 2.8697 | -0.0842 | -0.9793 | 0.7832 | -1.5591 | -0.8722 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 0 | -15.5235 | 1.8708 | 3.896 | 0.8458 | 0.9194 | -4.7588 | -15.5235 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | 6.8026 | 2.8566 | 1.831 | 0.9212 | -2.584 | 6.8026 | QC'd by "Asinex Ltd." |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.00123 uM | Activity at 0.00610 uM | Activity at 0.00630 uM | Activity at 0.013 uM | Activity at 0.025 uM | Activity at 0.042 uM | Activity at 0.068 uM | Activity at 0.120 uM | Activity at 0.202 uM | Activity at 0.314 uM | Activity at 0.611 uM | Activity at 1.089 uM | Activity at 1.568 uM | Activity at 3.058 uM | Activity at 5.503 uM | Activity at 7.834 uM | Activity at 15.29 uM | Activity at 27.41 uM | Activity at 39.61 uM | Activity at 75.76 uM | Activity at 149.6 uM | Activity at 201.4 uM | Activity at 319.7 uM | Activity at 605.8 uM | Activity at 817.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Activator | 112.2018 | 2659.1944 | 100 | Partial curve; high efficacy | -3.95 | 4.5045 | 0.9988 | 2689.24 | 30.0456 | 2.1 | 0 0 0 0 0 0 | 2175.7605 | -2.1864 | 18.441 | 20.7973 | 83.3849 | 426.7958 | 2175.7605 | QC'd by Microsource | ||||||||||||||||||||
| Activator | 0.1778 | 128.3128 | 95 | Complete curve; high efficacy | -6.75 | 4.9549 | 0.9927 | 134.4851 | 6.1723 | 1.1 | 0 0 0 0 0 1 | 14.509 | 5.6033 | 24.7938 | 142.7655 | 131.831 | 127.7753 | 14.509 | QC'd by SigmaAldrich | ||||||||||||||||||||
| Activator | 0.4467 | 126.1077 | 91 | Complete curve; high efficacy | -6.35 | 1.8617 | 0.9998 | 123.6363 | -2.4714 | 1.1 | 0 0 0 0 0 1 | 0.2688 | -2.5844 | 7.8161 | 80.257 | 120.2764 | 123.3895 | 0.2688 | QC'd by SigmaAldrich | ||||||||||||||||||||
| Activator | 1.122 | 117.1254 | 90 | Complete curve; high efficacy | -5.95 | 2.2481 | 0.9788 | 132.4265 | 15.3011 | 1.1 | 0 0 0 0 0 | 143.3187 | 15.8094 | 39.5652 | 122.9227 | 119.7824 | 143.3187 | QC'd by Tocris | |||||||||||||||||||||
| Activator | 112.2018 | 1122.1776 | 71 | Partial curve; high efficacy | -3.95 | 4.5045 | 0.9983 | 1140.5688 | 18.3912 | 2.1 | 0 0 0 0 0 | 922.7903 | 3.2305 | 7.5889 | 41.6506 | 204.8302 | 922.7903 | QC'd by Timtec | |||||||||||||||||||||
| Activator | 100 | 709.5673 | 58 | Partial curve; high efficacy | -4 | 3.99 | 0.9988 | 700.7079 | -8.8594 | 2.1 | 0 0 0 0 0 0 | 592.8155 | -15.9019 | -8.6532 | 4.5286 | -20.153 | 176.4838 | 592.8155 | QC'd by CarsonNewman-SPECS | ||||||||||||||||||||
| Activator | 79.4328 | 826.4076 | 57 | Partial curve; high efficacy | -4.1 | 4.095 | 0.9972 | 826.7667 | 0.3591 | 2.1 | 0 0 0 0 0 0 | 665.6736 | -2.5729 | -3.4508 | -16.7617 | 25.5851 | 154.5978 | 665.6736 | QC'd by Prestwick Chemical; Inc. | ||||||||||||||||||||
| Activator | 100 | 589.9325 | 55 | Partial curve; high efficacy | -4 | 3.2475 | 0.984 | 613.2979 | 23.3654 | 2.1 | 0 0 0 0 0 0 | 498.6162 | -5.747 | 1.059 | 37.6543 | 62.5313 | 194.9599 | 498.6162 | QC'd by CarsonNewman-SPECS | ||||||||||||||||||||
| Activator | 112.2018 | 558.6566 | 55 | Partial curve; high efficacy | -3.95 | 4.5045 | 0.9992 | 557.2619 | -1.3947 | 2.1 | 0 0 0 0 0 | 448.681 | -6.8565 | -3.8767 | 7.0632 | 81.1858 | 448.681 | QC'd by Vitas | |||||||||||||||||||||
| Activator | 100 | 612.4753 | 55 | Partial curve; high efficacy | -4 | 4.5045 | 0.9972 | 611.2868 | -1.1885 | 2.1 | 0 0 0 0 0 0 | 533.4091 | -10.048 | -5.6002 | -8.2068 | 21.4265 | 142.7223 | 533.4091 | QC'd by Pharmacopeia | ||||||||||||||||||||
| Activator | 100 | 511.5518 | 53 | Partial curve; high efficacy | -4 | 4.4495 | 0.9965 | 517.5467 | 5.995 | 2.1 | 0 0 0 0 0 0 | 453.9884 | -10.4867 | 10.4448 | 3.9744 | 21.1983 | 121.4017 | 453.9884 | QC'd by CarsonNewman-SPECS | ||||||||||||||||||||
| Activator | 112.2018 | 440.1981 | 52 | Partial curve; high efficacy | -3.95 | 4.095 | 0.9989 | 439.2753 | -0.9228 | 2.1 | 0 0 0 0 0 | 348.6312 | -5.1918 | -3.3018 | 6.9705 | 74.6909 | 348.6312 | QC'd by Sequoia | |||||||||||||||||||||
| Activator | 100 | 497.635 | 52 | Partial curve; high efficacy | -4 | 3.6772 | 0.9977 | 486.8252 | -10.8098 | 2.1 | 0 0 0 0 0 0 | 401.671 | -14.9427 | -21.3461 | -13.1864 | 2.6858 | 130.5049 | 401.671 | QC'd by Pharmacopeia | ||||||||||||||||||||
| Activator | 100 | 438.5085 | 51 | Partial curve; high efficacy | -4 | 4.9549 | 0.9987 | 437.7956 | -0.7128 | 2.1 | 0 0 0 0 0 0 | 392.29 | -7.2531 | 0.2913 | -4.176 | 9.3666 | 93.145 | 392.29 | QC'd by Pharmacopeia | ||||||||||||||||||||
| Activator | 56.2341 | 819.9718 | 50 | Partial curve; high efficacy | -4.25 | 3.2475 | 0.9993 | 802.9227 | -17.049 | 2.1 | 0 0 0 0 0 | 787.1792 | -7.4836 | -10.9833 | -14.2075 | 580.1833 | 787.1792 | QC'd by NCI | |||||||||||||||||||||
| Activator | 112.2018 | 363.641 | 50 | Partial curve; high efficacy | -3.95 | 4.9549 | 0.9972 | 355.9752 | -7.6658 | 2.1 | 0 0 0 0 0 0 | 293.7089 | -16.7363 | 0.4741 | -6.1211 | -4.3689 | 34.2599 | 293.7089 | QC'd by Pharmacopeia | ||||||||||||||||||||
| Activator | 112.2018 | 363.0297 | 50 | Partial curve; high efficacy | -3.95 | 4.5045 | 0.9992 | 370.4299 | 7.4002 | 2.1 | 0 0 0 0 0 0 | 299.7006 | 3.6943 | 4.7004 | 13.0282 | 5.8575 | 63.7543 | 299.7006 | QC'd by Pharmacopeia | ||||||||||||||||||||
| Activator | 100 | 295.8134 | 48 | Partial curve; high efficacy | -4 | 3.6272 | 0.9992 | 302.0389 | 6.2255 | 2.1 | 0 0 0 0 0 0 | 251.6991 | 2.6798 | 8.4811 | 8.6778 | 9.6504 | 86.3825 | 251.6991 | QC'd by CarsonNewman-SPECS | ||||||||||||||||||||
| Activator | 100 | 233.3469 | 46 | Partial curve; high efficacy | -4 | 4.5045 | 0.9961 | 221.7227 | -11.6242 | 2.1 | 0 0 0 0 0 0 | 192.4676 | -6.6471 | -16.5394 | -18.4762 | -5.6031 | 42.3638 | 192.4676 | QC'd by CarsonNewman-SPECS | ||||||||||||||||||||
| Activator | 112.2018 | 234.6061 | 46 | Partial curve; high efficacy | -3.95 | 4.9549 | 0.984 | 235.2356 | 0.6295 | 2.1 | 0 0 0 0 0 0 | 197.0148 | 0.9163 | -4.5136 | 1.9482 | 17.442 | 18.7867 | 197.0148 | QC'd by Pharmacopeia |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.00123 uM | Activity at 0.00610 uM | Activity at 0.00630 uM | Activity at 0.013 uM | Activity at 0.025 uM | Activity at 0.042 uM | Activity at 0.068 uM | Activity at 0.120 uM | Activity at 0.202 uM | Activity at 0.314 uM | Activity at 0.611 uM | Activity at 1.089 uM | Activity at 1.568 uM | Activity at 3.058 uM | Activity at 5.503 uM | Activity at 7.834 uM | Activity at 15.29 uM | Activity at 27.41 uM | Activity at 39.61 uM | Activity at 75.76 uM | Activity at 149.6 uM | Activity at 201.4 uM | Activity at 319.7 uM | Activity at 605.8 uM | Activity at 817.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 4.9549 | 0.7824 | 1.5059 | 12.5 | 4 | 0 0 0 0 0 0 | 2.5014 | 8.6579 | 16.7333 | 7.679 | -0.4118 | 3.2398 | 2.5014 | QC'd by Pharmacopeia | ||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.5059 | 2 | 22.5 | 4 | 0 0 0 0 0 0 | 6.2536 | 23.1671 | 31.5741 | 20.3971 | 12.3231 | 23.6931 | 6.2536 | QC'd by Pharmacopeia | ||||||||||||||||||||||||
| Inactive | 0 | 3.0654 | 0.4875 | 6 | 14 | 4 | 0 0 0 0 0 0 | 7.1178 | 13.8537 | 13.0635 | 10.2396 | 19.9104 | 9.8496 | 7.1178 | QC'd by Pharmacopeia | ||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.8513 | -6.1222 | 14.5 | 4 | 0 0 0 0 0 0 | -2.6019 | 18.6181 | 15.6971 | 11.9589 | 10.6497 | 12.3116 | -2.6019 | QC'd by Pharmacopeia | ||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.444 | 1 | -8.9353 | 4 | 0 0 0 0 0 0 | 4.128 | -6.6128 | 2.8591 | 5.135 | -4.2457 | -1.6866 | 4.128 | QC'd by Pharmacopeia | ||||||||||||||||||||||||
| Inactive | 0 | 0.9 | 0.6078 | 1.5 | 7 | 4 | 0 0 0 0 0 0 | 3.2802 | 4.9355 | 7.5212 | 2.2467 | 1.4536 | 0.7626 | 3.2802 | QC'd by Pharmacopeia | ||||||||||||||||||||||||
| Inactive | 0 | 4 | 15.8078 | 23.8467 | 15.2102 | 5.4007 | 17.1177 | 11.7038 | 15.8078 | QC'd by Pharmacopeia | |||||||||||||||||||||||||||||
| Inactive | 0 | 4 | -4.3249 | 4.3564 | 0.9262 | -8.2609 | 6.6136 | 3.2318 | -4.3249 | QC'd by Pharmacopeia | |||||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.386 | 6.5 | 16 | 4 | 0 0 0 0 0 1 | 18.5613 | 14.4696 | 22.6167 | 10.2425 | 16.2585 | 8.0741 | 18.5613 | QC'd by Pharmacopeia | ||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.7935 | 15 | -5.3851 | 4 | 0 0 0 0 0 0 | 16.1015 | -1.1543 | 20.9641 | 12.4561 | 14.2395 | 11.4227 | 16.1015 | QC'd by Pharmacopeia | ||||||||||||||||||||||||
| Inactive | 0 | 4.5045 | 0.9473 | 10.5 | 22 | 4 | 0 0 0 0 0 0 | 8.6846 | 21.3965 | 22.3063 | 12.7817 | 10.4065 | 12.724 | 8.6846 | QC'd by Pharmacopeia | ||||||||||||||||||||||||
| Inactive | 0 | 0.9 | 0.7228 | 2.6804 | 26 | 4 | 0 0 0 0 0 0 | -2.7663 | 19.5819 | 6.4245 | 5.729 | 8.0359 | 4.8741 | -2.7663 | QC'd by Pharmacopeia | ||||||||||||||||||||||||
| Inactive | 0 | 4.4495 | 0.861 | 16.5 | 8.5 | 4 | 0 0 0 0 0 1 | 9.315 | 8.5106 | 10.8538 | 6.2271 | 15.3684 | 16.5398 | 9.315 | QC'd by Pharmacopeia | ||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.5741 | 10.5 | 0.7083 | 4 | 0 0 0 0 0 0 | 12.2191 | 4.1249 | -2.3265 | 14.4634 | 3.8399 | 10.7866 | 12.2191 | QC'd by Pharmacopeia | ||||||||||||||||||||||||
| Inactive | 0 | 4 | 9.7084 | 13.4221 | 8.3748 | 0.3338 | 10.1018 | 18.0457 | 9.7084 | QC'd by Pharmacopeia | |||||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.4502 | -7.4141 | 8.5 | 4 | 0 0 0 0 0 0 | -4.5118 | 9.0559 | 14.9898 | -2.0146 | 10.2874 | 8.4395 | -4.5118 | QC'd by Pharmacopeia | ||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.6758 | 28 | 0.2443 | 4 | 0 0 0 0 0 0 | 23.0495 | 7.0826 | -6.4631 | 4.1349 | 2.386 | -6.0302 | 23.0495 | QC'd by Pharmacopeia | ||||||||||||||||||||||||
| Inactive | 0 | 4.4495 | 0.7608 | -2.5925 | 6.5 | 4 | 0 0 0 0 0 1 | 8.9695 | 3.4459 | 5.6768 | 9.8855 | -0.0456 | -2.1604 | 8.9695 | QC'd by Pharmacopeia | ||||||||||||||||||||||||
| Inactive | 0 | 2.6384 | 0.665 | 13.5 | 20 | 4 | 0 0 0 0 0 0 | 13.5742 | 16.0359 | 22.5098 | 21.2723 | 19.3862 | 14.3408 | 13.5742 | QC'd by Pharmacopeia | ||||||||||||||||||||||||
| Inactive | 0 | 4 | -3.2632 | -16.2622 | -13.7616 | -11.6684 | -9.5243 | -17.6211 | -3.2632 | QC'd by Prestwick Chemical; Inc. |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Inhibition | >= | 25 | % |
| Inhibition | >= | 25 | % |
| Inhibition | >= | 25 | % |
| Inhibition | >= | 25 | % |
| Inhibition | >= | 25 | % |
| Inhibition | >= | 25 | % |
| Inhibition | >= | 25 | % |
| Inhibition | >= | 25 | % |
| Inhibition | >= | 25 | % |
| Inhibition | >= | 25 | % |
| Inhibition | >= | 25 | % |
| Inhibition | >= | 25 | % |
| Inhibition | >= | 25 | % |
| Inhibition | >= | 25 | % |
| Inhibition | >= | 25 | % |
| Inhibition | >= | 25 | % |
| Inhibition | >= | 25 | % |
| Inhibition | >= | 25 | % |
| Inhibition | >= | 25 | % |
| Inhibition | >= | 25 | % |
| Phenotype | Potency | Efficacy | Analysis Comment | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.00174 uM | Activity at 0.00357 uM | Activity at 0.00697 uM | Activity at 0.016 uM | Activity at 0.028 uM | Activity at 0.056 uM | Activity at 0.105 uM | Activity at 0.226 uM | Activity at 0.447 uM | Activity at 0.627 uM | Activity at 0.951 uM | Activity at 1.818 uM | Activity at 2.333 uM | Activity at 4.073 uM | Activity at 6.884 uM | Activity at 11.29 uM | Activity at 15.41 uM | Activity at 25.59 uM | Activity at 50.19 uM | Activity at 58.90 uM | Activity at 114.8 uM | Activity at 162.0 uM | Activity at 229.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Activator | 100 | 38.2868 | Single point of activity | -4 | 4.9549 | 0.9173 | 40 | 1.7132 | 3 | 0 0 0 0 0 | 30.0132 | 5.2309 | 2.1349 | 2.7977 | -1.489 | 30.0132 | QC'd by "Asinex Ltd." | |||||||||||||||||||
| Activator | 100 | 54.6995 | Single point of activity | -4 | 4.9549 | 0.9067 | 56.2988 | 1.5993 | 3 | 0 0 0 0 0 | 42.8693 | 6.5044 | 4.3471 | -0.522 | -3.4058 | 42.8693 | QC'd by "Asinex Ltd." | |||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -17.2476 | 21.6169 | 12.7311 | 22.8702 | 20.8427 | -17.2476 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||
| Activator | 100 | 74.7794 | Single point of activity | -4 | 4.9549 | 0.9041 | 76.0108 | 1.2314 | 3 | 0 0 0 0 0 | 57.8804 | 6.7166 | 3.0104 | 3.7559 | -6.8905 | 57.8804 | QC'd by "Asinex Ltd." | |||||||||||||||||||
| Activator | 100 | 53.1278 | Single point of activity | -4 | 4.9549 | 0.9205 | 64.5427 | 11.4149 | 3 | 0 0 0 0 0 | 51.5124 | 12.0687 | 10.6696 | 16.4441 | 7.3638 | 51.5124 | QC'd by "Asinex Ltd." | |||||||||||||||||||
| Activator | 89.1251 | 88.3489 | Single point of activity | -4.05 | 4.9549 | 0.8504 | 83.4345 | -4.9144 | 3 | 0 0 0 0 0 | 66.09 | -2.4773 | 2.699 | 3.4126 | -18.2031 | 66.09 | QC'd by "Asinex Ltd." | |||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | 28.3132 | 7.6044 | 7.1621 | 1.8797 | -18.6884 | 28.3132 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 | -12.1963 | 15.5341 | 6.1257 | -12.1963 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||||
| Activator | 70.7946 | 131.9739 | Single point of activity | -4.15 | 4.9549 | 0.9814 | 124.2791 | -7.6948 | 3 | 0 0 0 0 | 113.1868 | -14.9551 | 3.8059 | -12.5697 | 113.1868 | QC'd by "Asinex Ltd." | ||||||||||||||||||||
| Activator | 50.1187 | 98.8583 | Partial curve; high efficacy; poor fit | -4.3 | 2.8473 | 0.9993 | 127.1199 | 28.2616 | 2.3 | 0 0 0 | 118.3612 | 29.7145 | 27.0534 | 118.3612 | QC'd by "Asinex Ltd." | |||||||||||||||||||||
| Activator | 89.1251 | 52.8332 | Single point of activity | -4.05 | 4.9549 | 0.8839 | 46.5982 | -6.2351 | 3 | 0 0 0 0 0 | 35.9582 | -5.7785 | 0.0051 | -3.002 | -11.6645 | 35.9582 | QC'd by "Asinex Ltd." | |||||||||||||||||||
| Activator | 44.6684 | 58.1237 | Single point of activity | -4.35 | 3.132 | 1 | 63.6237 | 5.5 | 3 | 0 0 0 | 60.693 | 5.2497 | 5.4646 | 60.693 | QC'd by "Asinex Ltd." | |||||||||||||||||||||
| Activator | 100 | 32 | Partial curve; partial efficacy; poor fit | -4 | 4.9549 | 0.7933 | 42 | 10 | 2.4 | 0 0 0 0 0 | 31.927 | 6.4109 | 17.9669 | 11.7318 | 10.1379 | 31.927 | QC'd by "Asinex Ltd." | |||||||||||||||||||
| Activator | 70.7946 | 52.3872 | Partial curve; partial efficacy; poor fit | -4.15 | 3.132 | 0.9366 | 88.8106 | 36.4234 | 2.4 | 0 0 0 | 79.2341 | 43.0009 | 30.195 | 79.2341 | QC'd by "Asinex Ltd." | |||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | 10.1042 | -2.0932 | -3.6864 | -11.1533 | -2.2306 | 10.1042 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||
| Activator | 35.4813 | 94.2201 | Single point of activity | -4.45 | 1.7137 | 1 | 103.2201 | 9 | 3 | 1 0 0 | 91.9965 | 33.4991 | 9.8887 | 91.9965 | QC'd by "Asinex Ltd." | |||||||||||||||||||||
| Activator | 89.1251 | 188.8272 | Single point of activity | -4.05 | 4.9549 | 0.9819 | 184.3761 | -4.4511 | 3 | 0 0 0 0 0 | 142.9272 | -4.9415 | 0.8751 | 3.841 | 0.2429 | 142.9272 | QC'd by "Asinex Ltd." | |||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | 15.1304 | -16.5373 | -21.4322 | -21.4132 | -27.9881 | 15.1304 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||
| Activator | 89.1251 | 54.5907 | Single point of activity | -4.05 | 4.9549 | 0.8982 | 43.8763 | -10.7143 | 3 | 0 0 0 0 0 | 34.3843 | -5.7785 | -4.8931 | -14.2749 | -14.7248 | 34.3843 | QC'd by "Asinex Ltd." | |||||||||||||||||||
| Activator | 56.2341 | 79.3018 | Partial curve; high efficacy; poor fit | -4.25 | 3.132 | 0.9915 | 106.1029 | 26.8011 | 2.3 | 0 0 0 | 98.2435 | 30.6599 | 23.0391 | 98.2435 | QC'd by "Asinex Ltd." |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.00123 uM | Activity at 0.00246 uM | Activity at 0.00610 uM | Activity at 0.00630 uM | Activity at 0.011 uM | Activity at 0.025 uM | Activity at 0.045 uM | Activity at 0.067 uM | Activity at 0.120 uM | Activity at 0.202 uM | Activity at 0.314 uM | Activity at 0.611 uM | Activity at 1.089 uM | Activity at 1.568 uM | Activity at 3.058 uM | Activity at 5.503 uM | Activity at 7.834 uM | Activity at 15.29 uM | Activity at 27.41 uM | Activity at 39.61 uM | Activity at 75.76 uM | Activity at 149.6 uM | Activity at 201.4 uM | Activity at 319.7 uM | Activity at 605.8 uM | Activity at 817.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 4.9549 | 0.8563 | -9.9979 | -3.182 | 4 | 0 0 0 0 0 0 | -8.823 | -2.9167 | -5.5515 | -1.8183 | -11.2482 | -10.2408 | -8.823 | QC'd by Microsource | |||||||||||||||||||||||||
| Inactive | 0 | 1.5386 | 0.564 | 4 | -4.8546 | 4 | 0 0 0 0 0 1 | -7.5471 | -0.6835 | -9.0455 | -3.7039 | -1.1903 | 3.153 | -7.5471 | QC'd by Microsource | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.431 | -21.0949 | 2.1993 | 4 | 0 0 0 0 0 0 | -29.6624 | -1.0839 | -27.7771 | -29.2982 | -9.5254 | -9.846 | -29.6624 | QC'd by Microsource | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.3341 | -1.3603 | -6.9124 | 4 | 0 0 0 0 0 1 | -15.5699 | -9.927 | -2.5767 | -5.8552 | -8.5221 | -2.3836 | -15.5699 | QC'd by Microsource | |||||||||||||||||||||||||
| Inhibitor | 0.8913 | 14.1351 | 0 | Complete curve; partial efficacy; poor fit | -6.05 | 2.1211 | 0.6534 | -22.6728 | -8.5377 | -1.4 | 0 0 0 0 0 0 | -21.1521 | -8.7814 | -12.9514 | -21.2535 | -30.9774 | -17.0722 | -21.1521 | QC'd by Microsource | |||||||||||||||||||||
| Inactive | 0 | 3.132 | 0.4725 | 0.5 | -4.2284 | 4 | 0 0 0 0 0 0 | -0.2612 | -1.9763 | -2.0592 | -8.107 | -2.1288 | 0.8201 | -0.2612 | QC'd by Microsource | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.4917 | -10.967 | -2.3149 | 4 | 0 0 0 0 0 0 | -10.1405 | -1.5124 | -2.5506 | -5.4129 | -17.8892 | -4.0897 | -10.1405 | QC'd by Microsource | |||||||||||||||||||||||||
| Inactive | 0 | 3.99 | 0.5924 | -19.9348 | 0 | 4 | 0 0 0 0 0 0 | -28.6957 | -6.2302 | 5.7918 | -15.0449 | -23.6413 | -7.309 | -28.6957 | QC'd by Microsource | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.4102 | -6.1308 | 5 | 4 | 0 0 0 0 0 0 | -4.355 | 0.8289 | 8.6021 | -2.8349 | -16.359 | 2.161 | -4.355 | QC'd by Microsource | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.369 | -1.5 | -14.3369 | 4 | 0 0 0 0 0 1 | -9.3021 | -12.7808 | 2.0015 | -0.2528 | -12.5875 | 4.4401 | -9.3021 | QC'd by Microsource | |||||||||||||||||||||||||
| Inhibitor | 0.7079 | 23.6221 | 0 | Complete curve; partial efficacy; poor fit | -6.15 | 3.0654 | 0.6513 | -24.5288 | -0.9067 | -1.4 | 0 0 0 0 0 1 | -13.9864 | -1.5889 | -9.6741 | -27.4469 | -33.3677 | -12.1786 | -13.9864 | QC'd by Microsource | |||||||||||||||||||||
| Inactive | 0 | 4 | -22.4775 | -11.6889 | -11.6628 | -13.5576 | -20.9035 | -8.6191 | -22.4775 | QC'd by Microsource | ||||||||||||||||||||||||||||||
| Inactive | 0 | 0.8 | 0.7088 | -25.4933 | -11.6918 | 4 | 0 0 0 0 0 0 | -24.5778 | -16.5266 | -8.0765 | -17.2318 | -20.0221 | -22.1348 | -24.5778 | QC'd by Microsource | |||||||||||||||||||||||||
| Inhibitor | 0.1778 | 19.9985 | 0 | Complete curve; partial efficacy; poor fit | -6.75 | 4.9549 | 0.6578 | -21.9347 | -1.9361 | -1.4 | 0 0 0 0 0 0 | -23.6561 | -4.5301 | -30.7789 | -20.7284 | -19.2667 | -15.4849 | -23.6561 | QC'd by Microsource | |||||||||||||||||||||
| Inactive | 0 | 1 | 0.9184 | -24.9585 | -2.7331 | 4 | 0 0 0 0 0 1 | -15.8401 | -9.7776 | -20.4013 | -20.4952 | -26.2154 | -25.1202 | -15.8401 | QC'd by Microsource | |||||||||||||||||||||||||
| Inactive | 0 | 4 | -16.8662 | -15.0798 | -16.9114 | -17.163 | -13.1564 | -16.5558 | -16.8662 | QC'd by Microsource | ||||||||||||||||||||||||||||||
| Inactive | 0 | 4 | 7.7575 | 3.3126 | 6.1383 | 6.2047 | -2.0209 | 6.2212 | 7.7575 | QC'd by Microsource | ||||||||||||||||||||||||||||||
| Inactive | 0 | 4 | 3.7597 | 9.7909 | 7.0224 | 3.0975 | -6.8965 | 12.3146 | 3.7597 | QC'd by Microsource | ||||||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.6335 | -4.9129 | 6 | 4 | 0 0 0 0 0 0 | -8.8467 | 6.1191 | 5.3496 | 5.0731 | -9.0941 | 2.984 | -8.8467 | QC'd by Microsource | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.7097 | -7.2734 | 0 | 4 | 0 0 0 0 0 0 | -5.915 | 1.1538 | -1.0587 | 0.2688 | -11.4778 | -4.1213 | -5.915 | QC'd by Microsource |
| Concentration uM | Data readout |
|---|---|
| 33 | 55 |
| 33 | 63 |
| 33 | 65 |
| 33 | 63 |
| 33 | 61 |
| 33 | 62 |
| 33 | 61 |
| 33 | 58 |
| 33 | 71 |
| 33 | 61 |
| 33 | 64 |
| 33 | 83 |
| 33 | 158 |
| 33 | 84 |
| 33 | 104 |
| 33 | 60 |
| 33 | 62 |
| 33 | 59 |
| 33 | 58 |
| 33 | 59 |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0009200000 uM | Activity at 0.00184 uM | Activity at 0.00456 uM | Activity at 0.00471 uM | Activity at 0.00850 uM | Activity at 0.018 uM | Activity at 0.034 uM | Activity at 0.050 uM | Activity at 0.090 uM | Activity at 0.151 uM | Activity at 0.235 uM | Activity at 0.457 uM | Activity at 0.814 uM | Activity at 1.171 uM | Activity at 2.284 uM | Activity at 4.113 uM | Activity at 5.853 uM | Activity at 11.42 uM | Activity at 20.49 uM | Activity at 29.59 uM | Activity at 56.64 uM | Activity at 111.7 uM | Activity at 150.6 uM | Activity at 238.8 uM | Activity at 452.6 uM | Activity at 611.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 3.6272 | 0.8626 | -16.9749 | 3 | 4 | 0 0 0 0 0 0 | -11.3522 | 4.4122 | -0.1869 | 3.8551 | -9.0486 | -22.4791 | -11.3522 | QC'd by SigmaAldrich | |||||||||||||||||||||||||
| Inactive | 0 | 1.21 | 0.9115 | 1 | 26.5 | 4 | 0 0 0 0 0 0 | 3.0879 | 22.5222 | 31.9661 | 22.8496 | 17.2717 | 6.5589 | 3.0879 | QC'd by NCI | |||||||||||||||||||||||||
| Inactive | 0 | 0.3 | 0.7243 | -12.8995 | 38 | 4 | 0 0 0 0 0 0 | -10.7496 | 28.5168 | 21.9546 | 5.2096 | 6.0738 | 11.3009 | -10.7496 | QC'd by Prestwick Chemical; Inc. | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.8029 | -15.6993 | -1.5 | 4 | 0 0 0 0 0 0 | -11.416 | -1.5504 | -1.249 | -4.6581 | -0.4266 | 0.4639 | -11.416 | QC'd by BIOMOL | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.6678 | -24.4602 | 3.4359 | 4 | 0 0 0 0 0 1 | -5.4651 | 2.872 | 2.434 | -38.4104 | -25.2406 | -9.2436 | -5.4651 | QC'd by BIOMOL | |||||||||||||||||||||||||
| Inactive | 0 | 2.4064 | 0.4215 | 1 | 17 | 4 | 0 0 0 0 0 0 | 5.8729 | 19.3202 | 14.8828 | 8.6332 | 24.907 | 11.2979 | 5.8729 | QC'd by BIOMOL | |||||||||||||||||||||||||
| Inactive | 0 | 0.6 | 0.7078 | -8.3138 | 14.5 | 4 | 0 0 0 0 0 0 | -10.7777 | 11.8187 | 1.9932 | 1.9062 | -11.5115 | -0.0866 | -10.7777 | QC'd by BIOMOL | |||||||||||||||||||||||||
| Inactive | 0 | 3.99 | 0.916 | 12.5 | 29 | 4 | 0 0 0 0 0 0 | 11.3216 | 25.3511 | 10.2782 | 12.6928 | 12.0425 | 15.0596 | 11.3216 | QC'd by BIOMOL | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.7598 | -8.0307 | 2 | 4 | 0 0 0 0 0 0 | -6.9632 | -1.9133 | 5.8317 | -9.609 | -8.7246 | -6.018 | -6.9632 | QC'd by SigmaAldrich | |||||||||||||||||||||||||
| Inactive | 0 | 0.7 | 0.6402 | -18.8089 | -2.3735 | 4 | 0 0 0 0 0 0 | -14.8407 | -3.9662 | -6.7181 | -0.3112 | -9.968 | -9.2615 | -14.8407 | QC'd by Microsource | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.9739 | -11.7501 | 2 | 4 | 0 0 0 0 0 0 | -11.6929 | 3.078 | 0.2437 | 2.2683 | -12.7084 | -10.568 | -11.6929 | QC'd by Microsource | |||||||||||||||||||||||||
| Inactive | 0 | 0.5 | 0.7605 | -11.0605 | 6 | 4 | 0 0 0 0 0 0 | -14.6337 | 3.6876 | -3.5123 | -6.8473 | -7.5675 | -5.2666 | -14.6337 | QC'd by BIOMOL | |||||||||||||||||||||||||
| Inactive | 0 | 4 | -7.53 | 4.7778 | -6.7829 | -15.1322 | -23.649 | 9.0847 | -7.53 | QC'd by Prestwick Chemical; Inc. | ||||||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.6409 | -3.2949 | 14 | 4 | 0 0 0 0 0 1 | 12.9818 | 17.651 | 4.102 | 20.6219 | 2.497 | -3.5791 | 12.9818 | QC'd by BIOMOL | |||||||||||||||||||||||||
| Inactive | 0 | 1.8265 | 0.7407 | -32.7287 | -10.9373 | 4 | 0 0 0 0 0 0 | -28.3802 | -13.7631 | -19.1044 | -5.7811 | -12.8137 | -32.2739 | -28.3802 | QC'd by Tocris | |||||||||||||||||||||||||
| Activator | 39.8107 | 46.538 | 0 | Single point of activity | -4.4 | 4.4495 | 0.7454 | 56.6458 | 10.1078 | 3 | 0 0 0 0 0 1 | 17.1415 | 13.5032 | 25.5832 | 14.464 | 6.9538 | 49.1102 | 17.1415 | QC'd by SigmaAldrich | |||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.5359 | -17.7206 | 3.5 | 4 | 0 0 0 0 0 0 | -16.8505 | -6.866 | 13.1002 | -5.4009 | 12.3928 | -11.0619 | -16.8505 | QC'd by SigmaAldrich | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.657 | 1.1082 | 10.5 | 4 | 0 0 0 0 0 1 | 10.7172 | 11.3518 | 5.1253 | 15.2488 | -0.3265 | 2.2476 | 10.7172 | QC'd by Prestwick Chemical; Inc. | |||||||||||||||||||||||||
| Inactive | 0 | 0.7 | 0.842 | -14.4407 | 10.5 | 4 | 0 0 0 0 0 0 | -8.7006 | 13.0238 | 6.2792 | 7.2892 | 3.5691 | 0.9878 | -8.7006 | QC'd by BIOMOL | |||||||||||||||||||||||||
| Inactive | 0 | 1.01 | 0.8718 | 2.4065 | -26.9475 | 4 | 0 0 0 0 0 1 | -20.1909 | -25.9748 | -30.373 | -20.9376 | -21.2882 | -7.9946 | -20.1909 | QC'd by Prestwick Chemical; Inc. |
| No. of GreenCells | No. of RedCells | GreenCells_Normalized | RedCells_Normalized | RedCells/GreenCells_Normalized |
|---|---|---|---|---|
| 1789 | 1180 | 0.88 | 1.08 | 1.22 |
| 1961 | 1081 | 0.97 | 0.99 | 1.02 |
| 1876 | 1291 | 0.93 | 1.18 | 1.27 |
| 2244 | 1094 | 1.11 | 1 | 0.9 |
| 2275 | 1210 | 1.12 | 1.11 | 0.98 |
| 1995 | 1398 | 0.98 | 1.28 | 1.3 |
| 2123 | 1293 | 1.05 | 1.18 | 1.13 |
| 2281 | 1227 | 1.13 | 1.12 | 1 |
| 1964 | 1090 | 0.97 | 1 | 1.03 |
| 2110 | 1295 | 1.04 | 1.18 | 1.14 |
| 2342 | 1361 | 1.16 | 1.24 | 1.08 |
| 2014 | 1316 | 0.99 | 1.2 | 1.21 |
| 2021 | 1270 | 1 | 1.16 | 1.16 |
| 2160 | 1287 | 1.07 | 1.18 | 1.1 |
| 2022 | 1197 | 1 | 1.09 | 1.1 |
| 1798 | 1082 | 0.89 | 0.99 | 1.11 |
| 1938 | 1199 | 1.08 | 1.06 | 0.98 |
| 2000 | 1260 | 1.12 | 1.11 | 0.99 |
| 1971 | 1201 | 1.1 | 1.06 | 0.96 |
| 2100 | 1130 | 1.17 | 1 | 0.85 |
| Phenotype | Potency | Efficacy | Analysis Comment | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0003270000 uM | Activity at 0.0007732774 uM | Activity at 0.00163 uM | Activity at 0.00369 uM | Activity at 0.00818 uM | Activity at 0.020 uM | Activity at 0.030 uM | Activity at 0.047 uM | Activity at 0.101 uM | Activity at 0.151 uM | Activity at 0.243 uM | Activity at 0.477 uM | Activity at 0.759 uM | Activity at 1.287 uM | Activity at 2.393 uM | Activity at 3.818 uM | Activity at 6.336 uM | Activity at 11.99 uM | Activity at 19.37 uM | Activity at 31.37 uM | Activity at 60.11 uM | Activity at 107.2 uM | Activity at 158.4 uM | Activity at 229.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 4 | 0 0 0 0 0 | 1.4694 | -3.5669 | -6.235 | 2.8586 | 1.8042 | 1.4694 | QC'd by "Chem Div" | ||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -4.2631 | 8.2218 | 8.0811 | 10.2927 | -3.9947 | -4.2631 | QC'd by "Chem Div" | ||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | 6.0369 | 0.3398 | -2.1048 | -8.1695 | -3.6822 | 6.0369 | QC'd by "Chem Div" | ||||||||||||||||||||||||||||
| Inactive | 4 | -2.0565 | 1.7294 | -3.5894 | -1.2575 | -0.5402 | -2.0565 | QC'd by "Chem Div" | |||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 1 | 2.3149 | 1.0048 | 4.6369 | -1.9963 | -3.3543 | 2.3149 | QC'd by "Chem Div" | ||||||||||||||||||||||||||||
| Inactive | 4 | 7.2748 | 7.1515 | 6.1372 | 1.5197 | 5.2332 | 7.2748 | QC'd by "Chem Div" | |||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | 1.006 | -3.3873 | -7.786 | -9.3037 | -9.1761 | 1.006 | QC'd by "Chem Div" | ||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -0.0368 | -9.4458 | -10.5155 | -9.0065 | -12.9141 | -0.0368 | QC'd by "Chem Div" | ||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | 2.6 | -7.8084 | -12.3007 | -2.0954 | -6.6887 | 2.6 | QC'd by "Chem Div" | ||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -11.4867 | -18.9051 | -17.4955 | -19.0735 | -9.6682 | -11.4867 | QC'd by "Chem Div" | ||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -7.5605 | -17.2173 | -11.0038 | -16.5656 | -22.4025 | -7.5605 | QC'd by "Chem Div" | ||||||||||||||||||||||||||||
| Inactive | 4 | -7.5451 | -1.1939 | -1.3084 | -5.8268 | -5.3206 | -7.5451 | QC'd by "Chem Div" | |||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 1 | -5.5852 | -4.3753 | -1.0046 | -3.1641 | -10.1524 | -5.5852 | QC'd by "Chem Div" | ||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | 1.1172 | -6.0391 | 7.0118 | 9.0446 | 1.6533 | 1.1172 | QC'd by "Chem Div" | ||||||||||||||||||||||||||||
| Inactive | 4 | 2.3359 | 1.2518 | 1.6626 | -0.9325 | -0.9194 | 2.3359 | QC'd by "Chem Div" | |||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 | -19.5354 | 0.3984 | -4.1147 | 2.1883 | -19.5354 | QC'd by "Chem Div" | |||||||||||||||||||||||||||||
| Inactive | 4 | -5.6552 | -4.6769 | -1.9378 | -0.5867 | -3.224 | -5.6552 | QC'd by "Chem Div" | |||||||||||||||||||||||||||||
| Inactive | 4 | -11.3738 | -10.4148 | -13.8912 | -10.4252 | -7.8961 | -11.3738 | QC'd by "Chem Div" | |||||||||||||||||||||||||||||
| Inactive | 4 | -6.1571 | -8.7102 | -2.9113 | -5.2229 | -3.4369 | -6.1571 | QC'd by "Chem Div" | |||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 1 | -7.3803 | -8.8177 | -11.1654 | -6.5301 | -15.9483 | -7.3803 | QC'd by "Chem Div" |
| Phenotype | Potency | Efficacy | Analysis Comment | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.00366 uM | Activity at 0.018 uM | Activity at 0.023 uM | Activity at 0.046 uM | Activity at 0.073 uM | Activity at 0.091 uM | Activity at 0.165 uM | Activity at 0.229 uM | Activity at 0.457 uM | Activity at 0.575 uM | Activity at 0.940 uM | Activity at 1.600 uM | Activity at 2.289 uM | Activity at 3.140 uM | Activity at 4.699 uM | Activity at 9.139 uM | Activity at 11.40 uM | Activity at 21.25 uM | Activity at 28.60 uM | Activity at 57.06 uM | Activity at 80.69 uM | Activity at 114.0 uM | Activity at 162.0 uM | Activity at 229.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 4 | 0 0 0 0 0 0 | -8.5357 | 4.3179 | -3.0782 | 18.2044 | 1.4021 | -0.6071 | -8.5357 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||
| Inhibitor | 14.1254 | 94.1071 | Partial curve; partial efficacy | -4.85 | 1 | 0.9973 | -87.1071 | 7 | -2.2 | 0 0 0 0 0 | -69.1326 | 7.6715 | 3.9436 | -8.8651 | -33.8049 | -69.1326 | QC'd by "Asinex Ltd." | ||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 1 | 20.2144 | 23.266 | 6.552 | 3.9866 | 5.6847 | 20.2144 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 | -2.4345 | 28.62 | 17.5955 | 28.0695 | -2.4345 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 1 | -7.2095 | -7.735 | -9.4851 | -7.9812 | 1.2883 | -3.8441 | -7.2095 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 0 | 1.1024 | 3.0058 | 5.1191 | 8.5622 | 10.0935 | 2.832 | 1.1024 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 0 | -16.9168 | 16.7339 | 20.4666 | 17.0396 | 14.9834 | 3.2447 | -16.9168 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | 16.95 | 3.6518 | 10.7006 | 12.1609 | 17.9239 | 16.95 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||||||
| Inactive | 4 | 7.8358 | 7.2347 | 7.1972 | -0.9941 | 5.7376 | 5.3715 | 7.8358 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -0.7814 | 9.8991 | 9.354 | 16.6393 | 7.5499 | -0.7814 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 1 | 20.4767 | 21.535 | 14.9912 | 12.9439 | 22.6391 | 20.4767 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -11.3724 | 5.1415 | -7.4919 | -12.7916 | -0.0848 | -11.3724 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 0 | -4.7334 | 4.0637 | 16.9474 | 20.3686 | 12.9839 | 14.7116 | -4.7334 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||
| Inactive | 4 | 5.3035 | 13.9672 | -6.2006 | 8.737 | 7.4415 | 9.3053 | 5.3035 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||||||
| Inactive | 4 | 13.7341 | 15.3823 | 8.8162 | 12.8936 | 14.0766 | 13.7341 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||||
| Inhibitor | 25.1189 | 70.1972 | Single point of activity | -4.6 | 1.6436 | 0.9919 | -61.6972 | 8.5 | -3 | 0 0 0 0 0 | -47.4341 | 10.3286 | 9.7459 | 3.6414 | -5.394 | -47.4341 | QC'd by "Asinex Ltd." | ||||||||||||||||||||
| Inactive | 4 | 3.4844 | 2.4373 | 2.7844 | 2.0269 | 2.7823 | 3.4844 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 1 | 1.6267 | 6.0455 | 2.2559 | 3.9025 | 7.0096 | -5.3015 | 1.6267 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 0 | -35.8234 | 9.2678 | 8.5627 | 21.1144 | 2.8518 | -2.6144 | -35.8234 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||
| Inactive | 4 | 1 0 0 0 0 0 | -8.4219 | 32.4292 | 6.1639 | 8.8591 | 10.3237 | 11.673 | -8.4219 | QC'd by "Asinex Ltd." |
| Phenotype | Potency | Efficacy | Analysis Comment | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.018 uM | Activity at 0.037 uM | Activity at 0.074 uM | Activity at 0.164 uM | Activity at 0.369 uM | Activity at 0.461 uM | Activity at 0.737 uM | Activity at 0.922 uM | Activity at 1.840 uM | Activity at 2.300 uM | Activity at 3.690 uM | Activity at 4.610 uM | Activity at 9.233 uM | Activity at 20.57 uM | Activity at 46.10 uM | Activity at 92.20 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 4 | 0 0 0 0 0 | 0.2596 | 10.769 | 4.1255 | -1.6909 | -0.7487 | 0.2596 | QC'd by "Chem Div" | ||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -0.8876 | -5.2018 | -3.6707 | 0.3303 | 2.9155 | -0.8876 | QC'd by "Chem Div" | ||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -4.2306 | -10.0984 | -0.7957 | -0.9322 | 2.0609 | -4.2306 | QC'd by "Chem Div" | ||||||||||||||||||||
| Inactive | 4 | 5.8218 | -1.6618 | -3.0553 | 9.7773 | -4.173 | 5.8218 | QC'd by "Chem Div" | |||||||||||||||||||||
| Inactive | 4 | -3.2651 | 11.605 | -17.8848 | 5.9785 | 14.3087 | -3.2651 | QC'd by "Chem Div" | |||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -7.241 | 3.2008 | 3.9728 | -4.5121 | 3.9811 | -7.241 | QC'd by "Chem Div" | ||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -9.807 | 8.9869 | 0.3484 | 0.3728 | 7.0197 | -9.807 | QC'd by "Chem Div" | ||||||||||||||||||||
| Cytotoxic | 17.7828 | 35.5846 | Partial curve; partial efficacy | -4.75 | 2.3031 | 0.9974 | -42.6167 | -7.0321 | -2.2 | 0 0 0 0 0 | -39.1036 | -6.2767 | -6.4175 | -8.2439 | -13.6777 | -39.1036 | QC'd by "Chem Div" | ||||||||||||
| Cytotoxic | 3.5481 | 40.0619 | Single point of activity | -5.45 | 4.9549 | 0.8999 | -40.3659 | -0.3039 | -3 | 0 0 0 0 1 | 2.6367 | -8.333 | 7.8061 | -1.7484 | -40.2332 | 2.6367 | QC'd by "Chem Div" | ||||||||||||
| Inactive | 4 | 0 0 0 0 1 | 0.5424 | 1.6591 | 9.6647 | 14.2749 | 15.5896 | 0.5424 | QC'd by "Chem Div" | ||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | 5.9628 | -8.298 | -2.3104 | 6.1361 | -3.4428 | 5.9628 | QC'd by "Chem Div" | ||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -1.0151 | -4.6247 | -5.8885 | -4.492 | -0.7127 | -1.0151 | QC'd by "Chem Div" | ||||||||||||||||||||
| Inactive | 4 | -0.9022 | -1.2889 | 13.9053 | -1.079 | 4.3101 | -0.9022 | QC'd by "Chem Div" | |||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -23.5202 | -1.5751 | 7.1469 | -12.6721 | 9.6037 | -23.5202 | QC'd by "Chem Div" | ||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 1 | -0.075 | -0.6173 | -0.8732 | 5.135 | 2.1913 | -0.075 | QC'd by "Chem Div" | ||||||||||||||||||||
| Cytotoxic | 35.4813 | 33.3813 | Single point of activity | -4.45 | 4.9549 | 0.4913 | -37.3813 | -4 | -3 | 0 0 0 0 0 | -30.3178 | -0.6381 | -23.6633 | -3.8386 | 6.0591 | -30.3178 | QC'd by "Chem Div" | ||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -17.414 | 0.1464 | -4.8771 | -5.0687 | -7.6162 | -17.414 | QC'd by "Chem Div" | ||||||||||||||||||||
| Inactive | 4 | -4.6673 | -7.1501 | -3.3264 | -4.1232 | -3.249 | -4.6673 | QC'd by "Chem Div" | |||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -17.3878 | 6.5726 | 2.9374 | -7.8375 | -3.1433 | -17.3878 | QC'd by "Chem Div" | ||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 1 | -10.2269 | -7.0609 | -5.5812 | -5.8217 | 2.0518 | -10.2269 | QC'd by "Chem Div" |
| Standard Type | Standard Relation | Standard Value | Standard Units | Data Validity Comment |
|---|---|---|---|---|
| Inhibition | = | 65.85 | % | |
| Inhibition | = | 63.37 | % | |
| Inhibition | = | 75.25 | % | |
| Inhibition | = | 97.38 | % | |
| Inhibition | = | 105.26 | % | |
| Inhibition | = | 97.94 | % | |
| Inhibition | = | 105.32 | % | |
| Inhibition | = | 99.4 | % | |
| Inhibition | = | 101.01 | % | |
| Inhibition | = | 86.27 | % | |
| Inhibition | = | 80.06 | % | |
| Inhibition | = | 89.01 | % | |
| Inhibition | = | 120.91 | % | |
| Inhibition | = | 102.46 | % | |
| Inhibition | = | 101.26 | % | |
| Inhibition | = | 90.74 | % | |
| Inhibition | = | 113.76 | % | |
| Inhibition | = | 82.92 | % | |
| Inhibition | = | 126.2 | % | |
| Inhibition | = | 116.63 | % |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Data Validity Comment |
|---|---|---|---|---|---|
| 0.63096 | Ki | = | 630.96 | nM | |
| 0.15849 | Ki | = | 158.49 | nM | |
| 15.8489 | Ki | = | 15848.93 | nM | |
| 39.8107 | Ki | = | 39810.72 | nM | |
| 1.25893 | Ki | = | 1258.93 | nM | |
| 1.25893 | Ki | = | 1258.93 | nM | |
| 50.1187 | Ki | = | 50118.72 | nM | |
| 6.30957 | Ki | = | 6309.57 | nM | |
| 3.98107 | Ki | = | 3981.07 | nM | |
| 0.1 | Ki | = | 100 | nM | |
| 0.31623 | Ki | = | 316.23 | nM | |
| 0.15849 | Ki | = | 158.49 | nM | |
| 0.79433 | Ki | = | 794.33 | nM | |
| 1.25893 | Ki | = | 1258.93 | nM |
| Phenotype | Potency | Efficacy | Analysis Comment | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.018 uM | Activity at 0.037 uM | Activity at 0.074 uM | Activity at 0.164 uM | Activity at 0.369 uM | Activity at 0.461 uM | Activity at 0.737 uM | Activity at 0.922 uM | Activity at 1.840 uM | Activity at 2.300 uM | Activity at 3.690 uM | Activity at 4.610 uM | Activity at 9.231 uM | Activity at 20.57 uM | Activity at 46.10 uM | Activity at 92.20 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 4 | 0 0 0 0 0 | 27.0569 | 9.9398 | 10.1515 | 0.1671 | 5.5721 | 27.0569 | QC'd by "Asinex Ltd." | ||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 1 | -4.9362 | -9.414 | 12.0824 | -11.0493 | -7.696 | -4.9362 | QC'd by "Asinex Ltd." | ||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 1 | 5.9595 | 4.342 | -1.5624 | -2.6449 | -8.9538 | 5.9595 | QC'd by "Asinex Ltd." | ||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -19.7473 | -1.448 | 7.5701 | -38.1554 | -17.3097 | -19.7473 | QC'd by "Asinex Ltd." | ||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -1.2351 | -5.5487 | -5.0573 | -16.6211 | 2.7653 | -1.2351 | QC'd by "Asinex Ltd." | ||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | 7.1959 | -7.7682 | 4.4899 | 3.3992 | 13.3707 | 7.1959 | QC'd by "Asinex Ltd." | ||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 1 | 8.9833 | 15.335 | 4.2535 | 4.1946 | -14.3236 | 8.9833 | QC'd by "Asinex Ltd." | ||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | 7.9022 | -10.5174 | 13.4936 | -10.4686 | 7.2323 | 7.9022 | QC'd by "Asinex Ltd." | ||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -11.8347 | 12.2839 | -2.7256 | -19.2666 | -5.8034 | -11.8347 | QC'd by "Asinex Ltd." | ||||||||||||||||||||
| Inhibitor | 35.4813 | 106.2444 | Single point of activity | -4.45 | 4.4495 | 0.9934 | -109.7251 | -3.4808 | -3 | 0 0 0 0 0 | -84.6645 | -7.4849 | -2.0755 | -4.8114 | 0.1432 | -84.6645 | QC'd by "Asinex Ltd." | ||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -3.6 | -2.0717 | 4.9414 | 15.4055 | -0.2463 | -3.6 | QC'd by "Asinex Ltd." | ||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | 0.7641 | 0 | 28.3456 | 12.1698 | 0.9078 | 0.7641 | QC'd by "Asinex Ltd." | ||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 1 | -3.7338 | -9.9559 | 0.3986 | 8.9255 | 12.5033 | -3.7338 | QC'd by "Asinex Ltd." | ||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -1.7797 | 3.883 | 1.182 | -4.185 | 1.7497 | -1.7797 | QC'd by "Asinex Ltd." | ||||||||||||||||||||
| Inhibitor | 15.8489 | 38.9608 | Single point of activity | -4.8 | 3.6772 | 0.9889 | -35.4608 | 3.5 | -3 | 0 0 0 0 0 | -32.884 | 2.0677 | 5.819 | 2.7318 | -1.3119 | -32.884 | QC'd by "Asinex Ltd." | ||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -3.797 | 8.4821 | -2.1836 | 12.76 | 5.4907 | -3.797 | QC'd by "Asinex Ltd." | ||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -18.7499 | 1.0272 | 3.815 | 20.5199 | 1.7606 | -18.7499 | QC'd by "Asinex Ltd." | ||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | 0.464 | 0 | 9.4101 | -6.5206 | 0.9067 | 0.464 | QC'd by "Asinex Ltd." | ||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | 0.2371 | 9.7122 | -4.6112 | -6.6419 | -3.2889 | 0.2371 | QC'd by "Asinex Ltd." | ||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 1 | 3.6799 | 4.8924 | 1.7621 | -1.6686 | -4.4945 | 3.6799 | QC'd by "Asinex Ltd." |
| Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|
| Inhibition | Not Active | |||
| Inhibition | = | 92 | % | |
| Inhibition | Not Active | |||
| Inhibition | Not Active | |||
| Inhibition | Not Active | |||
| Inhibition | Not Active | |||
| Inhibition | Not Active | |||
| Inhibition | Not Active | |||
| Inhibition | = | 93 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|
| Inhibition | Not Active | |||
| Inhibition | = | 99 | % | |
| Inhibition | Not Active | |||
| Inhibition | Not Active | |||
| Inhibition | Not Active | |||
| Inhibition | Not Active | |||
| Inhibition | Not Active | |||
| Inhibition | Not Active | |||
| Inhibition | = | 99 | % | |
| Inhibition | = | 90 | % |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Data Validity Comment |
|---|---|---|---|---|---|
| 76 | IC50 | = | 76000 | nM | |
| 7.8 | IC50 | = | 7800 | nM | |
| 12 | IC50 | = | 12000 | nM | |
| 3470 | IC50 | > | 3470000 | nM | Outside typical range |
| 10 | IC50 | = | 10000 | nM | |
| 11 | IC50 | = | 11000 | nM | |
| 7700 | IC50 | > | 7700000 | nM | Outside typical range |
| 1.7 | IC50 | = | 1700 | nM | |
| 1300 | IC50 | = | 1300000 | nM | Outside typical range |
| 5200 | IC50 | > | 5200000 | nM | Outside typical range |
| 8.1 | IC50 | = | 8100 | nM | |
| 143 | IC50 | = | 143000 | nM | Outside typical range |
| 7 | IC50 | = | 7000 | nM | |
| 13.5 | IC50 | = | 13500 | nM | |
| 85 | IC50 | = | 85000 | nM | |
| 2700 | IC50 | > | 2700000 | nM | Outside typical range |
| 1900 | IC50 | = | 1900000 | nM | Outside typical range |
| 0.4 | IC50 | = | 400 | nM | |
| 5000 | IC50 | > | 5000000 | nM | Outside typical range |
| 182 | IC50 | = | 182000 | nM | Outside typical range |
| Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|
| Inhibition | Not Active | |||
| Inhibition | = | 57 | % | |
| Inhibition | Not Active | |||
| Inhibition | Not Active | |||
| Inhibition | Not Active | |||
| Inhibition | Not Active | |||
| Inhibition | Not Active | |||
| Inhibition | Not Active | |||
| Inhibition | Not Active | |||
| Inhibition | = | 54 | % |
| PDBbind Data Link | Affinity_Quilifier | Ki | PubMed | Protein Target | Protein Name | MMDB | PDB |
|---|---|---|---|---|---|---|---|
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1mto | = | 0.11 | 12390023 | 1MTO_A,1MTO_B | 6-phosphofructokinase | 21480 | 1MTO |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1mu6 | = | 0.0042 | 12570369 | 1MU6_B | thrombin alpha | 26736 | 1MU6 |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1mue | = | 0.0023 | 12657281 | 1MUE_B | thrombin alpha | 26738 | 1MUE |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1mx1 | > | 100 | 12725862 | 1MX1_A | carboxylesterase i | 22651 | 1MX1 |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1mxo | = | 0.001 | 1MXO_A | beta-lactamase | 22061 | 1MXO | |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1my8 | = | 0.035 | 1MY8_A | beta-lactamase | 22064 | 1MY8 | |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1n1v | = | 140 | 12507479 | 1N1V_A | neuraminidase (sialidase) | 21810 | 1N1V |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1n2v | = | 83 | 12646024 | 1N2V_A | queuine tRNA-ribosyltransferase | 22661 | 1N2V |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1n3i | = | 0.0013 | 12755607 | 1N3I_A,1N3I_B | purine nucleoside phosphorylase | 24646 | 1N3I |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1n46 | = | 3.0E-5 | 12565933 | 1N46_A | thyroid hormone receptor beta-1 | 22662 | 1N46 |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1n4h | = | 0.28 | 12958591 | 1N4H_A | nuclear receptor ror-beta | 24647 | 1N4H |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1n5r | = | 2.2 | 12505979 | 1N5R_A | acetylcholinesterase | 21834 | 1N5R |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1n7i | = | 0.26 | 14695818 | 1N7I_A | phenylethanolamine n-methyltransferase | 25597 | 1N7I |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1nc1 | = | 0.75 | 12496243 | 1NC1_A,1NC1_B | mta/sah nucleosidase | 25250 | 1NC1 |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1nc3 | = | 10 | 12496243 | 1NC3_A,1NC3_B | mta/sah nucleosidase | 22390 | 1NC3 |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1nde | = | 0.015 | 12459017 | 1NDE_A | estrogen receptor beta | 21544 | 1NDE |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1ndz | = | 0.0077 | 14709046 | 1NDZ_A | adenosine deaminase | 25613 | 1NDZ |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1nhv | = | 2.2 | 12509436 | 1NHV_A | rna-dependent rna polymerase | 22403 | 1NHV |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1nny | = | 0.022 | 12670229 | 1NNY_A | tyrosine phosphatase 1b | 22696 | 1NNY |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1noj | = | 700 | 8652510 | 1NOJ_A | glycogen phosphorylase | 56992 | 1NOJ |
| FP_A | P Channel_A | S Channel_A | FP_B | P Channel_B | S Channel_B | Z-score_A | Z-score_B |
|---|---|---|---|---|---|---|---|
| 91.8 | 90.2 | 0.126 | 0.03 | ||||
| 93.2 | 94.9 | 0.261 | 0.457 | ||||
| 94.8 | 92.9 | 0.416 | 0.275 | ||||
| 89.9 | 85.7 | -0.058 | -0.379 | ||||
| 91.5 | 90.1 | 0.097 | 0.021 | ||||
| 88.7 | 89.6 | -0.174 | -0.025 | ||||
| 92.5 | 88.2 | 0.194 | -0.152 | ||||
| 91.7 | 91.6 | 0.116 | 0.157 | ||||
| 93.3 | 91.2 | 0.271 | 0.121 | ||||
| 90.5 | 86.6 | 0 | -0.297 | ||||
| 87.1 | 88.8 | -0.329 | -0.097 | ||||
| 87.6 | 85.8 | -0.28 | -0.37 | ||||
| 89.2 | 87.4 | -0.126 | -0.224 | ||||
| 87.2 | 86 | -0.319 | -0.351 | ||||
| 85.8 | 86.1 | -0.454 | -0.342 | ||||
| 88 | 92 | -0.242 | 0.193 | ||||
| 95.4 | 97.7 | 0.474 | 0.711 | ||||
| 98.6 | 97.5 | 0.784 | 0.693 | ||||
| 90 | 88.4 | -0.048 | -0.134 | ||||
| 98.6 | 93.6 | 0.784 | 0.338 |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| MCD | > | 640 | mg kg-1 |
| MCD | = | 1.25 | mg kg-1 |
| MCD | > | 640 | mg kg-1 |
| MCD | = | 80 | mg kg-1 |
| MCD | = | 40 | mg kg-1 |
| MCD | = | 160 | mg kg-1 |
| MCD | = | 640 | mg kg-1 |
| MCD | = | 80 | mg kg-1 |
| MCD | = | 160 | mg kg-1 |
| MCD | = | 40 | mg kg-1 |
| MCD | > | 640 | mg kg-1 |
| MCD | = | 640 | mg kg-1 |
| MCD | = | 40 | mg kg-1 |
| MCD | = | 160 | mg kg-1 |
| MCD | > | 640 | mg kg-1 |
| MCD | = | 640 | mg kg-1 |
| MCD | > | 640 | mg kg-1 |
| MCD | = | 20 | mg kg-1 |
| MCD | = | 160 | mg kg-1 |
| MCD | = | 40 | mg kg-1 |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.00111 uM | Activity at 0.00284 uM | Activity at 0.00446 uM | Activity at 0.00891 uM | Activity at 0.015 uM | Activity at 0.029 uM | Activity at 0.036 uM | Activity at 0.073 uM | Activity at 0.113 uM | Activity at 0.149 uM | Activity at 0.293 uM | Activity at 0.487 uM | Activity at 0.726 uM | Activity at 1.458 uM | Activity at 2.011 uM | Activity at 3.331 uM | Activity at 5.199 uM | Activity at 7.343 uM | Activity at 13.78 uM | Activity at 20.90 uM | Activity at 36.53 uM | Activity at 60.71 uM | Activity at 87.88 uM | Activity at 127.3 uM | Activity at 194.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 1.3987 | 0.9996 | -13.0836 | -0.5853 | 4 | 0 0 0 1 | -0.8016 | -2.9877 | -9.467 | -12.5697 | -0.8016 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||||
| Inhibitor | 12.5893 | 40.5111 | 10 | Single point of activity | -4.9 | 4.5045 | 0.9991 | -45.3562 | -4.8451 | -3 | 0 0 0 0 | -45.0493 | -5.3378 | -3.9936 | -8.2693 | -45.0493 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||
| Inactive | 0 | 4 | 0 | -2.0352 | 0 | 0 | 0 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||||||
| Inactive | 0 | 4 | 0 | 0 | 0 | -0.9941 | 0 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 1 | 0 | -13.6335 | 4 | 0 0 0 0 | 0 | -12.1946 | 0 | 0 | 0 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||||
| Inactive | 0 | 4 | 0 | 0 | 0 | 0 | 0 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||||||
| Inactive | 0 | 4 | -13.3369 | -12.1444 | -5.0835 | -13.8274 | -13.3369 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||||||
| Inactive | 0 | 4 | 0 | -4.5112 | -3.9568 | 0 | 0 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||||||
| Inactive | 0 | 4 | 0 | 0 | 0 | 0 | 0 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||||||
| Inactive | 0 | 1.8079 | 0.9998 | -19.413 | 1.5 | 4 | 0 0 0 1 | -2.2992 | 0 | -11.3763 | -18.6775 | -2.2992 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.7721 | 4 | -15.6398 | 4 | 0 0 0 0 | 0 | -10.469 | -15.9421 | -20.9499 | 0 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.9987 | -20.1455 | -0.5 | 4 | 0 0 0 0 | -19.2879 | 0 | -0.8113 | -0.6866 | -19.2879 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.9999 | -7.3207 | 0 | 4 | 0 0 0 0 | -6.934 | 0 | 0 | 0 | -6.934 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||||
| Inactive | 0 | 4 | -10.1341 | 0 | -23.8022 | -3.1543 | -10.1341 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||||||
| Inactive | 0 | 1.8265 | 0.9999 | -31.5926 | 1 | 4 | 0 0 0 1 | -8.4479 | 0 | -12.323 | -29.2439 | -8.4479 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||||
| Inactive | 0 | 0.7 | 0.9542 | 2 | -18.0981 | 4 | 0 0 0 0 | 0 | -15.9151 | -9.0083 | -6.2439 | 0 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.7994 | 0.5884 | -8.2 | 4 | 0 0 0 0 | -1.1763 | -9.1365 | -5.7126 | -9.75 | -1.1763 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||||
| Inactive | 0 | 0.6 | 0.9653 | -16.2314 | 0.756 | 4 | 0 0 0 0 | -14.3595 | -3.5367 | -8.6422 | -10.5182 | -14.3595 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||||
| Inactive | 0 | 4 | -3.3063 | -1.5829 | -0.4572 | 0 | -3.3063 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.7973 | -6.6878 | -1.5 | 4 | 0 0 0 1 | 0 | -2.5435 | 0 | -5.5731 | 0 | QC'd by "Asinex Ltd." |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| MED | = | 640 | mg kg-1 |
| MED | = | 0.63 | mg kg-1 |
| MED | > | 640 | mg kg-1 |
| MED | = | 20 | mg kg-1 |
| MED | = | 10 | mg kg-1 |
| MED | = | 40 | mg kg-1 |
| MED | = | 160 | mg kg-1 |
| MED | = | 20 | mg kg-1 |
| MED | = | 40 | mg kg-1 |
| MED | = | 20 | mg kg-1 |
| MED | > | 640 | mg kg-1 |
| MED | = | 640 | mg kg-1 |
| MED | = | 20 | mg kg-1 |
| MED | = | 20 | mg kg-1 |
| MED | = | 160 | mg kg-1 |
| MED | = | 640 | mg kg-1 |
| MED | > | 640 | mg kg-1 |
| MED | = | 2.5 | mg kg-1 |
| MED | = | 40 | mg kg-1 |
| MED | = | 20 | mg kg-1 |
| Standard Type | Standard Relation | Standard Value | Standard Units | Data Validity Comment |
|---|---|---|---|---|
| Inhibition | = | 89.51 | % | |
| Inhibition | = | 81.71 | % | |
| Inhibition | = | 65.47 | % | |
| Inhibition | = | 50.32 | % | |
| Inhibition | = | 112.43 | % | |
| Inhibition | = | 99.94 | % | |
| Inhibition | = | 101.75 | % | |
| Inhibition | = | 98.72 | % | |
| Inhibition | = | 104.08 | % | |
| Inhibition | = | 114.2 | % | |
| Inhibition | = | 97.5 | % | |
| Inhibition | = | 120.61 | % | |
| Inhibition | = | 45.56 | % | |
| Inhibition | = | 105.72 | % | |
| Inhibition | = | 107.28 | % | |
| Inhibition | = | 93.09 | % | |
| Inhibition | = | 84.51 | % | |
| Inhibition | = | 155.79 | % | Outside typical range |
| Inhibition | = | 97.26 | % | |
| Inhibition | = | 72.91 | % |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.00111 uM | Activity at 0.00284 uM | Activity at 0.00446 uM | Activity at 0.00891 uM | Activity at 0.015 uM | Activity at 0.029 uM | Activity at 0.036 uM | Activity at 0.073 uM | Activity at 0.113 uM | Activity at 0.149 uM | Activity at 0.293 uM | Activity at 0.487 uM | Activity at 0.726 uM | Activity at 1.458 uM | Activity at 2.011 uM | Activity at 3.331 uM | Activity at 5.199 uM | Activity at 7.343 uM | Activity at 13.78 uM | Activity at 20.90 uM | Activity at 36.52 uM | Activity at 60.71 uM | Activity at 87.88 uM | Activity at 127.3 uM | Activity at 194.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 1.4641 | 0.71 | -12.454 | -2 | 4 | 0 0 0 0 | -11.2117 | -5.2093 | 0.6206 | -7.2594 | -11.2117 | QC'd by "Chem Div" | ||||||||||||||||||||||||||
| Inactive | 0 | 4 | -11.3429 | -16.0267 | -12.2608 | -14.6132 | -11.3429 | QC'd by "Chem Div" | |||||||||||||||||||||||||||||||
| Inactive | 0 | 1.6259 | 0.9272 | -14.3148 | -0.877 | 4 | 0 0 0 0 | -15.2623 | -7.8142 | -13.6096 | -13.0621 | -15.2623 | QC'd by "Chem Div" | ||||||||||||||||||||||||||
| Inactive | 0 | 4 | -12.3142 | -9.814 | -12.586 | -8.4662 | -12.3142 | QC'd by "Chem Div" | |||||||||||||||||||||||||||||||
| Inactive | 0 | 4 | -8.2677 | -9.1999 | -12.2836 | -11.2753 | -8.2677 | QC'd by "Chem Div" | |||||||||||||||||||||||||||||||
| Inactive | 0 | 4.5045 | 0.9238 | -23.3577 | -9.0057 | 4 | 0 0 0 0 | -23.2147 | -6.6714 | -11.5717 | -9.7492 | -23.2147 | QC'd by "Chem Div" | ||||||||||||||||||||||||||
| Inhibitor | 11.2202 | 18.8957 | 21 | Partial curve; partial efficacy | -4.95 | 3.5117 | 0.9065 | -31.7758 | -12.8801 | -2.2 | 0 0 0 0 | -31.4798 | -16.0985 | -9.0667 | -16.5103 | -31.4798 | QC'd by "Chem Div" | ||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.8003 | -13.5254 | -8.8783 | 4 | 0 0 0 0 | -13.3545 | -10.4528 | -7.3986 | -12.9731 | -13.3545 | QC'd by "Chem Div" | ||||||||||||||||||||||||||
| Inactive | 0 | 2.3332 | 0.9015 | -5.5393 | 8 | 4 | 0 0 0 0 | -5.4494 | 5.4818 | 10.3071 | 0 | -5.4494 | QC'd by "Chem Div" | ||||||||||||||||||||||||||
| Inactive | 0 | 1.9673 | 0.9741 | -21.6735 | -12.4937 | 4 | 0 0 0 0 | -21.3946 | -13.4008 | -12.078 | -16.6303 | -21.3946 | QC'd by "Chem Div" | ||||||||||||||||||||||||||
| Inactive | 0 | 4 | -5.6419 | -17.3934 | -2.7552 | -14.5706 | -5.6419 | QC'd by "Chem Div" | |||||||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.8944 | -16.0102 | -8.6848 | 4 | 0 0 0 0 | -15.0085 | -7.2373 | -9.9603 | -8.6791 | -15.0085 | QC'd by "Chem Div" | ||||||||||||||||||||||||||
| Inactive | 0 | 1.5579 | 0.9997 | -19.5854 | -2.0513 | 4 | 0 0 0 1 | -5.8527 | -2.9594 | -9.4187 | -17.9878 | -5.8527 | QC'd by "Chem Div" | ||||||||||||||||||||||||||
| Inactive | 0 | 0.9 | 0.9974 | 18 | -20.2383 | 4 | 0 0 0 0 | 12.7737 | -17.6986 | -10.2115 | 1.1055 | 12.7737 | QC'd by "Chem Div" | ||||||||||||||||||||||||||
| Inactive | 0 | 1.8851 | 0.9998 | -14.291 | -6.7783 | 4 | 0 0 0 1 | -6.726 | -6.8986 | -8.4505 | -13.1591 | -6.726 | QC'd by "Chem Div" | ||||||||||||||||||||||||||
| Inactive | 0 | 0.9 | 0.9901 | -24.8053 | -6.5569 | 4 | 0 0 0 0 | -19.0044 | -6.7141 | -9.2211 | -12.2131 | -19.0044 | QC'd by "Chem Div" | ||||||||||||||||||||||||||
| Inhibitor | 10 | 25.7525 | 21 | Partial curve; partial efficacy | -5 | 4.9549 | 0.9958 | -34.5683 | -8.8157 | -2.2 | 0 0 0 0 | -34.709 | -9.7184 | -7.7631 | -13.3604 | -34.709 | QC'd by "Chem Div" | ||||||||||||||||||||||
| Inactive | 0 | 0.5 | 0.7446 | -13.2445 | -2.1109 | 4 | 0 0 0 0 | -9.3704 | -2.5924 | -6.2168 | -4.8236 | -9.3704 | QC'd by "Chem Div" | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.8017 | -7.4285 | -18.0168 | 4 | 0 0 0 0 | -7.4434 | -13.764 | -5.7738 | -9.5578 | -7.4434 | QC'd by "Chem Div" | ||||||||||||||||||||||||||
| Activator | 31.6228 | 49 | 0 | Partial curve; high efficacy | -4.5 | 0.8 | 0.9998 | 65 | 114 | 2.1 | 0 0 0 1 | 118.3965 | 112.9568 | 110.0983 | 102.4909 | 118.3965 | QC'd by "Chem Div" |
| Species | Strain | IsPseudotypeVirus | AssayMeth | CellType | CellType2 | Target | Mutations | EC50Mod | EC50 | EC50Unit | ECOtherPct | ECOtherPctUnit | ECOtherConc | ECOtherConcUnit | ToxAssayMeth | ToxCellType | CC50Mod | CC50 | CC50Unit | TIMod | TI | RelResFoldChg | Comments | Reference | Citation | Other Information |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HIV-1 | LAI | RT | HuT TK+ | HuT 78 | Reverse transcriptase | < | 1 | uM | 100 | % | 1 | uM | MTT | > | 10 | uM | > | 10 | HuT TK+=HuT 78 CELLS EXPRESSING HSV-1 THYMIDINE KINASE; MEASUREMENT WAS MADE ON DAY10 POSTINFECTION AT 10 TCID50 | 9281520 | USE OF HERPES SIMPLEX VIRUS THYMIDINE KINASE TO IMPROVE THE ANTIVIRAL ACTIVITY OF ZIDOVUDINE. Virology 1997, 235, 398-405. | |||||
| HIV-1 | MN | RT | HuT TK+ | HuT 78 | Reverse transcriptase | < | 0.3 | uM | 76.74 | % | 0.3 | uM | MTT | > | 10 | uM | > | 33.3 | HuT TK+=HuT 78 CELLS EXPRESSING HSV-1 THYMIDINE KINASE; MEASUREMENT WAS MADE ON DAY14 POSTINFECTION AT 10 TCID50 | 9281520 | USE OF HERPES SIMPLEX VIRUS THYMIDINE KINASE TO IMPROVE THE ANTIVIRAL ACTIVITY OF ZIDOVUDINE. Virology 1997, 235, 398-405. | |||||
| HIV-1 | MN | RT | HuT TK+ | HuT 78 | Reverse transcriptase | < | 0.3 | uM | 69 | % | 0.3 | uM | MTT | > | 10 | uM | > | 33.3 | HuT TK+=HuT 78 CELLS EXPRESSING HSV-1 THYMIDINE KINASE; MEASUREMENT WAS MADE ON DAY14 POSTINFECTION AT 100 TCID50 | 9281520 | USE OF HERPES SIMPLEX VIRUS THYMIDINE KINASE TO IMPROVE THE ANTIVIRAL ACTIVITY OF ZIDOVUDINE. Virology 1997, 235, 398-405. | |||||
| R5; CLINICAL ISOLATE | 1(JSL) | P24 | PBMC | Reverse transcriptase | MDR | 0.07 | uM | 90 | % | 1 | uM | MTT | > | 100 | uM | > | 1428 | HIV-1(JSL) WAS ISOLATED FROM PATIENTS WHO RECEIVED ANTIRETROVIRAL THERAPY FOR A LONG PERIOD AND WHOSE VIRUS ACQUIRED A NUMBER OF MUTATIONS IN THE RT- AND PR-ENCODING GENES; DETAILS OF MUTATIONS NOT GIVEN | 15280474 | SPIRODIKETOPIPERAZINE-BASED CCR5 INHIBITOR WHICH PRESERVES CC-CHEMOKINE/CCR5 INTERACTIONS AND EXERTS POTENT ACTIVITY AGAINST R5 HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 IN VITRO. Journal of Virology 2004, 78(16), 8654-8662. | ECOtherConcMod:> | |||||
| HIV-1 | NL4-3 | LUCIFERASE | 1G5 T | Reverse transcriptase | < | 1 | uM | 99 | % | 1 | uM | TRYPAN BLUE | > | 1 | uM | > | 1 | ASSAY WAS CONDUCTED ON DAY 3 POST-INFECTION | 16725040 | INHIBITION OF HIGHLY PRODUCTIVE HIV-1 INFECTION IN T CELLS, PRIMARY HUMAN MACROPHAGES, MICROGLIA, AND ASTROCYTES BY SARGASSUM FUSIFORME. AIDS Research and Therapy 2006, 3(1), 15 PP. | CCOtherPct:6 | CCOtherPctUnit:% | CCOtherConc:1 | CCOtherConcUnit:uM | |||||
| HIV-1 | NL4-3 | LUCIFERASE | 1G5 T | Reverse transcriptase | < | 1 | uM | 99 | % | 1 | uM | TRYPAN BLUE | > | 1 | uM | > | 1 | ASSAY WAS CONDUCTED ON DAY 5 POST-INFECTION | 16725040 | INHIBITION OF HIGHLY PRODUCTIVE HIV-1 INFECTION IN T CELLS, PRIMARY HUMAN MACROPHAGES, MICROGLIA, AND ASTROCYTES BY SARGASSUM FUSIFORME. AIDS Research and Therapy 2006, 3(1), 15 PP. | CCOtherPct:7 | CCOtherPctUnit:% | CCOtherConc:1 | CCOtherConcUnit:uM | |||||
| HIV-1 | NL4-3 | LUCIFERASE | 1G5 T | Reverse transcriptase | < | 1 | uM | 99 | % | 1 | uM | TRYPAN BLUE | > | 1 | uM | > | 1 | ASSAY WAS CONDUCTED ON DAY 7 POST-INFECTION | 16725040 | INHIBITION OF HIGHLY PRODUCTIVE HIV-1 INFECTION IN T CELLS, PRIMARY HUMAN MACROPHAGES, MICROGLIA, AND ASTROCYTES BY SARGASSUM FUSIFORME. AIDS Research and Therapy 2006, 3(1), 15 PP. | CCOtherPct:3 | CCOtherPctUnit:% | CCOtherConc:1 | CCOtherConcUnit:uM | |||||
| HIV-1 | LAV | RT | U1(THF-.alpha. STIM) | U1 | Tumor necrosis factor alpha | ~ | 30 | ug/mL | 70 | % | 50 | ug/mL | > | 50 | ug/mL | > | 1.66 | CHRONICALLY HIV-1 INFECTED PROMONOCYTE CELL LINE | 8327469 | THALIDOMIDE INHIBITS THE REPLICATION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1. Proceedings of the National Academy of Sciences of the United States of America 1993, 90, 5974-5978. | CCOtherPct:0 | CCOtherPctUnit:% | CCOtherConc:50 | CCOtherConcUnit:ug/mL | |||||
| HIV-1 | BaL | P24 (DAY 18) | MACROPHAGES(GM-CSF) | Macrophage | Ribonucleotide reductase | < | 10 | uM | 75 | % | 10 | uM | > | 1000 | uM | > | 10 | MAXIMAL P24 EXPRESSION AT DAY 18 | 7973634 | HYDROXYUREA AS AN INHIBITOR OF HUMAN IMMUNODEFICIENCY VIRUS-TYPE 1 REPLICATION. Science 1994, 266(5186), 801-805. | CCOtherPct:0 | CCOtherPctUnit:% | CCOtherConc:1000 | CCOtherConcUnit:uM | |||||
| HIV-1 | BaL | P24 (DAY 18) | MACROPHAGES(GM-CSF) | Macrophage | Ribonucleotide reductase | < | 10 | uM | 38 | % | 2 | uM | > | 1000 | uM | > | 10 | MAXIMAL P24 EXPRESSION AT DAY 18 | 7973634 | HYDROXYUREA AS AN INHIBITOR OF HUMAN IMMUNODEFICIENCY VIRUS-TYPE 1 REPLICATION. Science 1994, 266(5186), 801-805. | CCOtherPct:0 | CCOtherPctUnit:% | CCOtherConc:1000 | CCOtherConcUnit:uM | |||||
| HIV-1 | BaL | P24 (DAY 18) | MACROPHAGES(GM-CSF) | Macrophage | Ribonucleotide reductase | < | 10 | uM | 99 | % | 50 | uM | > | 1000 | uM | > | 10 | MAXIMAL P24 EXPRESSION AT DAY 18 | 7973634 | HYDROXYUREA AS AN INHIBITOR OF HUMAN IMMUNODEFICIENCY VIRUS-TYPE 1 REPLICATION. Science 1994, 266(5186), 801-805. | ECOtherPctMod:> | CCOtherPct:0 | CCOtherPctUnit:% | CCOtherConc:1000 | CCOtherConcUnit:uM | |||||
| HIV-1 | IIIB | RT | HT4(R116; AZT RESISTANT CELLS) | HT4 | Reverse transcriptase | ~ | 0.01 | uM | 70 | % | 0.01 | uM | ~` | 1 | uM | ~ | 100 | FLOXURIDINE APPEARS TO POTENTIATE AZT ACTIVITY AND ALSO HAVE SOME ANTI-HIV ACTIVITY IN AZT RESISTANT CELL LINES | 8827211 | USE OF FLOXURIDINE TO MODULATE THE ANTIVIRAL ACTIVITY OF ZIDOVUDINE. AIDS Research and Human Retroviruses 1996, 12(11), 965-968. | ECOtherPctMod:~ | CCOtherPct:35 | CCOtherPctUnit:% | CCOtherConc:.1 | CCOtherConcUnit:uM | |||||
| HIV-1 | 1 | .beta.GAL AS A MEASURE OF TAT-MEDIATED TRANSACTIVATION | HeLa H12(HIV-1 LTR-Laz, TAT) | HeLa | Tat:TAR/LTR | < | 0.1 | uM | 52 | % | 0.1 | uM | TRYPAN BLUE | > | 100 | uM | > | 1000 | DRUG AND RECOMBINANT TAT WERE INTRODUCED INTO CELLS THROUGH ELECTROPORATION | 9561563 | CURCUMIN AND CURCUMIN DERIVATIVES INHIBIT TAT-MEDIATED TRANSACTIVATION OF TYPE 1 HUMAN IMMUNODEFICIENCY VIRUS LONG TERMINAL REPEAT. Research in Virology 1998, 149(1), 43-52. | |||||
| HIV-1 | 1 | .beta.GAL AS A MEASURE OF TAT-MEDIATED TRANSACTIVATION | HeLa H12(HIV-1 LTR-Laz, TAT) | HeLa | Tat:TAR/LTR | < | 0.01 | uM | 78 | % | 0.01 | uM | TRYPAN BLUE | > | 100 | uM | > | 10000 | DRUG AND RECOMBINANT TAT WERE INTRODUCED INTO CELLS THROUGH ELECTROPORATION | 9561563 | CURCUMIN AND CURCUMIN DERIVATIVES INHIBIT TAT-MEDIATED TRANSACTIVATION OF TYPE 1 HUMAN IMMUNODEFICIENCY VIRUS LONG TERMINAL REPEAT. Research in Virology 1998, 149(1), 43-52. | |||||
| HIV-1 | IIIB | SYNCYT FORM | MOLT-4/H9(HIV-1(IIIB)) | MOLT-4 | gp120 | < | 1 | uM | 95 | % | 10 | uM | -100 | 10 | uM | > | 10 | CHRONICALLY INFECTED H9 CELLS | 9343823 | TRIAZINE DYES INHIBIT HIV-1 ENTRY BY BINDING TO ENVELOPE GLYCOPROTEINS. Microbiology and Immunology 1997, 41(9), 717-724. | CCOtherPct:30 | CCOtherPctUnit:% | CCOtherConc:10 | CCOtherConcUnit:uM | |||||
| HIV-1 | 1 | .beta.GAL AS A MEASURE OF TAT-MEDIATED TRANSACTIVATION | HeLa H12(HIV-1 LTR-Laz, TAT) | HeLa | Tat:TAR/LTR | < | 0.01 | uM | 75 | % | 0.01 | uM | TRYPAN BLUE | > | 100 | uM | > | 10000 | DRUG AND RECOMBINANT TAT WERE INTRODUCED INTO CELLS THROUGH ELECTROPORATION | 9561563 | CURCUMIN AND CURCUMIN DERIVATIVES INHIBIT TAT-MEDIATED TRANSACTIVATION OF TYPE 1 HUMAN IMMUNODEFICIENCY VIRUS LONG TERMINAL REPEAT. Research in Virology 1998, 149(1), 43-52. | |||||
| HIV-1 | 1 | P24 | MT-4 | Integrase | < | 0.25 | uM | 95 | % | 0.25 | uM | MICROSCOPIC EXAMINATION | > | 20 | uM | > | 80 | IN THE PRESENCE OF 50% NHS | 16554152 | A SERIES OF 5-AMINOSUBSTITUTED 4-FLUOROBENZYL-8-HYDROXY-[1,6]NAPHTHYRIDINE-7-CARBOXAMIDE HIV-1 INTEGRASE INHIBITORS. Bioorganic & Medical Chemistry Letters 2006, 16(11), 2900-2904. | ECOtherPctMod:> | |||||
| HIV-1 | 1 | P24 | MT-4 | Integrase | < | 0.103 | uM | 95 | % | 0.103 | uM | MICROSCOPIC EXAMINATION | > | 20 | uM | > | 194 | IN THE PRESENCE OF 10% FBS | 16554152 | A SERIES OF 5-AMINOSUBSTITUTED 4-FLUOROBENZYL-8-HYDROXY-[1,6]NAPHTHYRIDINE-7-CARBOXAMIDE HIV-1 INTEGRASE INHIBITORS. Bioorganic & Medical Chemistry Letters 2006, 16(11), 2900-2904. | ECOtherPctMod:> | |||||
| HIV-1 | NL4-3 | RT | MT-4 | Reverse transcriptase | < | 1 | uM | 100 | % | 1 | uM | WST-8 | > | 1 | uM | > | 1 | MEASUREMENTS WERE MADE ON DAY 4, 6 AND 8 POST INFECTION | 15371436 | POLYARGININE INHIBITS GP160 PROCESSING BY FURIN AND SUPPRESSES PRODUCTIVE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INFECTION. The Journal of Biological Chemistry 2004, 279(47), 49055-49063. | ||||||
| HIV-1 | LAI | RT | HuT 78 | Reverse transcriptase | < | 1 | uM | 57.14 | % | 1 | uM | MTT | > | 10 | uM | > | 10 | MEASUREMENT WAS MADE ON DAY10 POSTINFECTION AT 10 TCID50 | 9281520 | USE OF HERPES SIMPLEX VIRUS THYMIDINE KINASE TO IMPROVE THE ANTIVIRAL ACTIVITY OF ZIDOVUDINE. Virology 1997, 235, 398-405. |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Data Validity Comment |
|---|---|---|---|---|---|
| 0.008 | IC50 | = | 8 | nM | |
| 3900 | IC50 | > | 3900000 | nM | Outside typical range |
| 4000 | IC50 | > | 4000000 | nM | Outside typical range |
| 6600 | IC50 | = | 6600000 | nM | Outside typical range |
| 1200 | IC50 | = | 1200000 | nM | Outside typical range |
| 0.017 | IC50 | = | 17 | nM | |
| 32 | IC50 | = | 32000 | nM | |
| 31 | IC50 | = | 31000 | nM | |
| 7700 | IC50 | > | 7700000 | nM | Outside typical range |
| 1.0E-4 | IC50 | = | 0.1 | nM | |
| 2500 | IC50 | > | 2500000 | nM | Outside typical range |
| 3700 | IC50 | = | 3700000 | nM | Outside typical range |
| 0.005 | IC50 | = | 5 | nM | |
| 0.002 | IC50 | = | 2 | nM | |
| 9.0E-4 | IC50 | = | 0.9 | nM | |
| 3600 | IC50 | > | 3600000 | nM | Outside typical range |
| 227 | IC50 | = | 227000 | nM | Outside typical range |
| 407 | IC50 | = | 407000 | nM | Outside typical range |
| 0.036 | IC50 | = | 36 | nM | |
| 0.001 | IC50 | = | 1 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Data Validity Comment |
|---|---|---|---|---|---|
| 10.5 | IC50 | = | 10500 | nM | |
| 3900 | IC50 | > | 3900000 | nM | Outside typical range |
| 4000 | IC50 | > | 4000000 | nM | Outside typical range |
| 7500 | IC50 | = | 7500000 | nM | Outside typical range |
| 3000 | IC50 | = | 3000000 | nM | Outside typical range |
| 3300 | IC50 | = | 3300000 | nM | Outside typical range |
| 22 | IC50 | = | 22000 | nM | |
| 61 | IC50 | = | 61000 | nM | |
| 7700 | IC50 | > | 7700000 | nM | Outside typical range |
| 0.019 | IC50 | = | 19 | nM | |
| 2500 | IC50 | > | 2500000 | nM | Outside typical range |
| 2200 | IC50 | = | 2200000 | nM | Outside typical range |
| 0.3 | IC50 | = | 300 | nM | |
| 0.01 | IC50 | = | 10 | nM | |
| 3.4 | IC50 | = | 3400 | nM | |
| 3600 | IC50 | > | 3600000 | nM | Outside typical range |
| 121 | IC50 | = | 121000 | nM | Outside typical range |
| 394 | IC50 | = | 394000 | nM | Outside typical range |
| 350 | IC50 | > | 350000 | nM | Outside typical range |
| 0.18 | IC50 | = | 180 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Data Validity Comment |
|---|---|---|---|---|---|
| 0.24 | IC50 | = | 240 | nM | |
| 3900 | IC50 | > | 3900000 | nM | Outside typical range |
| 4000 | IC50 | > | 4000000 | nM | Outside typical range |
| 6000 | IC50 | = | 6000000 | nM | Outside typical range |
| 1300 | IC50 | = | 1300000 | nM | Outside typical range |
| 2400 | IC50 | = | 2400000 | nM | Outside typical range |
| 5.7 | IC50 | = | 5700 | nM | |
| 5 | IC50 | = | 5000 | nM | |
| 7700 | IC50 | > | 7700000 | nM | Outside typical range |
| 0.4 | IC50 | = | 400 | nM | |
| 1200 | IC50 | = | 1200000 | nM | Outside typical range |
| 885 | IC50 | = | 885000 | nM | Outside typical range |
| 0.5 | IC50 | = | 500 | nM | |
| 1.0E-5 | IC50 | = | 0.01 | nM | |
| 3.1 | IC50 | = | 3100 | nM | |
| 8200 | IC50 | = | 8200000 | nM | Outside typical range |
| 55.7 | IC50 | = | 55700 | nM | |
| 19 | IC50 | = | 19000 | nM | |
| 291 | IC50 | = | 291000 | nM | Outside typical range |
| 0.01 | IC50 | = | 10 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Data Validity Comment |
|---|---|---|---|---|---|
| 5.1 | IC50 | = | 5100 | nM | |
| 3900 | IC50 | > | 3900000 | nM | Outside typical range |
| 4000 | IC50 | > | 4000000 | nM | Outside typical range |
| 6400 | IC50 | = | 6400000 | nM | Outside typical range |
| 630 | IC50 | = | 630000 | nM | Outside typical range |
| 16.3 | IC50 | = | 16300 | nM | |
| 10 | IC50 | = | 10000 | nM | |
| 12 | IC50 | = | 12000 | nM | |
| 7700 | IC50 | > | 7700000 | nM | Outside typical range |
| 0.021 | IC50 | = | 21 | nM | |
| 980 | IC50 | = | 980000 | nM | Outside typical range |
| 1700 | IC50 | = | 1700000 | nM | Outside typical range |
| 3.2 | IC50 | = | 3200 | nM | |
| 6.0E-5 | IC50 | = | 0.06 | nM | |
| 0.057 | IC50 | = | 57 | nM | |
| 8200 | IC50 | = | 8200000 | nM | Outside typical range |
| 65.1 | IC50 | = | 65100 | nM | |
| 61 | IC50 | = | 61000 | nM | |
| 27.3 | IC50 | = | 27300 | nM | |
| 0.028 | IC50 | = | 28 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Data Validity Comment |
|---|---|---|---|---|---|
| 4 | IC50 | = | 4000 | nM | |
| 3900 | IC50 | > | 3900000 | nM | Outside typical range |
| 4000 | IC50 | > | 4000000 | nM | Outside typical range |
| 2500 | IC50 | = | 2500000 | nM | Outside typical range |
| 580 | IC50 | = | 580000 | nM | Outside typical range |
| 35 | IC50 | = | 35000 | nM | |
| 3.5 | IC50 | = | 3500 | nM | |
| 6.5 | IC50 | = | 6500 | nM | |
| 7700 | IC50 | > | 7700000 | nM | Outside typical range |
| 0.003 | IC50 | = | 3 | nM | |
| 780 | IC50 | = | 780000 | nM | Outside typical range |
| 833 | IC50 | = | 833000 | nM | Outside typical range |
| 0.07 | IC50 | = | 70 | nM | |
| 0.4 | IC50 | = | 400 | nM | |
| 0.14 | IC50 | = | 140 | nM | |
| 3600 | IC50 | > | 3600000 | nM | Outside typical range |
| 32 | IC50 | = | 32000 | nM | |
| 1000 | IC50 | = | 1000000 | nM | Outside typical range |
| 42.6 | IC50 | = | 42600 | nM | |
| 0.028 | IC50 | = | 28 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Data Validity Comment |
|---|---|---|---|---|---|
| 12 | IC50 | = | 12000 | nM | |
| 3900 | IC50 | > | 3900000 | nM | Outside typical range |
| 4000 | IC50 | > | 4000000 | nM | Outside typical range |
| 2500 | IC50 | = | 2500000 | nM | Outside typical range |
| 540 | IC50 | = | 540000 | nM | Outside typical range |
| 900 | IC50 | = | 900000 | nM | Outside typical range |
| 7.9 | IC50 | = | 7900 | nM | |
| 8.2 | IC50 | = | 8200 | nM | |
| 7700 | IC50 | > | 7700000 | nM | Outside typical range |
| 0.8 | IC50 | = | 800 | nM | |
| 850 | IC50 | = | 850000 | nM | Outside typical range |
| 1000 | IC50 | = | 1000000 | nM | Outside typical range |
| 0.5 | IC50 | = | 500 | nM | |
| 1.5 | IC50 | = | 1500 | nM | |
| 8.2 | IC50 | = | 8200 | nM | |
| 3600 | IC50 | > | 3600000 | nM | Outside typical range |
| 39 | IC50 | = | 39000 | nM | |
| 570 | IC50 | = | 570000 | nM | Outside typical range |
| 355 | IC50 | > | 355000 | nM | Outside typical range |
| 0.4 | IC50 | = | 400 | nM |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Activity | = | 0 | % |
| Activity | = | 12 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Activity | = | 5 | % |
| TotalNuclei_24h_A | %Pos_24h_A | TotalNuclei_24h_B | %Pos_24h_B | TotalNuclei_48h_A | %Pos_48h_A | TotalNuclei_48h_B | %Pos_48h_B | TotalNuclei_Norm_A_24h | %Pos_Norm_A_24h | TotalNuclei_Norm_B_24h | %Pos_Norm_B_24h | TotalNuclei_Norm_A_48h | %Pos_Norm_A_48h | TotalNuclei_Norm_B_48h | %Pos_Norm_B_48h | Avg_TotalNuclei_Norm_24h | Avg_%Pos_Norm_24h | Avg_TotalNuclei_Norm_48h | Avg_%Pos_Norm_48h | Viability 24h | Viability 48h | Hit 24h | Hit 48h | Molar Concentration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1208 | 0.166 | 1233 | 0.324 | 1534 | 0.0652 | 1567 | 0.128 | 107.5241301 | 0.014207932 | 114.2526206 | 0.301056209 | 111.5408212 | -0.200936304 | 115.8595194 | -0.078440722 | 110.8883753 | 0.15763207 | 113.7001703 | -0.139688513 | High | High | Low | Low | 123 uM |
| 1278 | 0.0782 | 1173 | 0.341 | 1644 | 0.304 | 1525 | 0.262 | 113.754833 | -0.105094533 | 108.6928824 | 0.324276435 | 119.5391852 | 0.073652809 | 112.754159 | 0.076453966 | 111.2238577 | 0.109590951 | 116.1466721 | 0.075053388 | High | High | Low | Low | 41 uM |
| 1191 | 0.336 | 1251 | 0.24 | 1484 | 0.135 | 1553 | 0.258 | 106.0109594 | 0.245203592 | 115.9205421 | 0.186320973 | 107.9052012 | -0.120675332 | 114.8243993 | 0.071830244 | 110.9657507 | 0.215762282 | 111.3648002 | -0.024422544 | High | High | Low | Low | 13.7 uM |
| 1235 | 0.081 | 1129 | 0 | 1539 | 0.065 | 1463 | 0.273 | 109.9274012 | -0.101289898 | 104.615741 | -0.141493985 | 111.9043832 | -0.201166278 | 108.1700555 | 0.089169202 | 107.2715711 | -0.121391942 | 110.0372193 | -0.055998538 | High | High | Low | Low | 4.6 uM |
| 1274 | 0.0785 | 1127 | 0.177 | 1643 | 0.365 | 1410 | 0.213 | 113.3987928 | -0.104686893 | 104.4304164 | 0.100269547 | 119.4664728 | 0.143794919 | 104.2513863 | 0.019813371 | 108.9146046 | -0.002208673 | 111.8589295 | 0.081804145 | High | High | Low | Low | 1.5 uM |
| 1212 | 0 | 1184 | 0 | 1575 | 0 | 1383 | 0.0723 | 107.8801702 | -0.211352536 | 109.7121677 | -0.141493985 | 114.5220296 | -0.27590787 | 102.2550832 | -0.142826051 | 108.796169 | -0.176423261 | 108.3885564 | -0.209366961 | High | High | Low | Low | 500 nM |
| 1232 | 0 | 1268 | 0 | 1361 | 0.0735 | 1411 | 0.142 | 109.6603711 | -0.211352536 | 117.4958012 | -0.141493985 | 98.96157604 | -0.191392377 | 104.3253235 | -0.062257695 | 113.5780861 | -0.176423261 | 101.6434498 | -0.126825036 | High | High | Low | Low | 10 mM |
| 1145 | 0.0873 | 1164 | 0.258 | 1473 | 0.0679 | 1479 | 0.203 | 101.9164975 | -0.092729471 | 107.8589216 | 0.210907095 | 107.1053648 | -0.197831653 | 109.3530499 | 0.008254066 | 104.8877095 | 0.059088812 | 108.2292074 | -0.094788793 | High | High | Low | Low | 3.333 mM |
| 1374 | 0.291 | 1147 | 0.0872 | 1603 | 0.374 | 1447 | 0.0691 | 122.2997969 | 0.184057682 | 106.2836625 | -0.022387884 | 116.5579768 | 0.154143755 | 106.987061 | -0.146525029 | 114.2917297 | 0.080834899 | 111.7725189 | 0.003809363 | High | High | Low | Low | 1.111 mM |
| 1208 | 0.166 | 1215 | 0 | 1445 | 0.138 | 1552 | 0.0644 | 107.5241301 | 0.014207932 | 112.5846991 | -0.141493985 | 105.0694176 | -0.11722572 | 114.7504621 | -0.151957902 | 110.0544146 | -0.063643027 | 109.9099399 | -0.134591811 | High | High | Low | Low | 370 uM |
| 1127 | 0.177 | 1208 | 0.248 | 1448 | 0.207 | 1355 | 0.221 | 100.3143167 | 0.02915471 | 111.936063 | 0.197248139 | 105.2875548 | -0.037884645 | 100.1848429 | 0.029060815 | 106.1251899 | 0.113201424 | 102.7361989 | -0.004411915 | High | High | Low | Low | 123 uM |
| 1264 | 0.0791 | 1133 | 0.0883 | 1421 | 0.493 | 1365 | 0.147 | 112.5086924 | -0.103871615 | 104.9863902 | -0.020885398 | 103.32432 | 0.290978363 | 100.9242144 | -0.056478042 | 108.7475413 | -0.062378506 | 102.1242672 | 0.11725016 | High | High | Low | Low | 41 uM |
| 1316 | 0.076 | 1210 | 0 | 1570 | 0.318 | 1472 | 0.204 | 117.1372145 | -0.108083888 | 112.1213876 | -0.141493985 | 114.1584676 | 0.089750998 | 108.8354898 | 0.009409997 | 114.6293011 | -0.124788937 | 111.4969787 | 0.049580497 | High | High | Low | Low | 13.7 uM |
| 1347 | 0.148 | 1270 | 0.0787 | 1558 | 0.257 | 1546 | 0.259 | 119.8965258 | -0.010250432 | 117.6811258 | -0.033997997 | 113.2859188 | 0.019608888 | 114.3068392 | 0.072986175 | 118.7888258 | -0.022124215 | 113.796379 | 0.046297531 | High | High | Low | Low | 4.6 uM |
| 1211 | 0.165 | 1181 | 0.339 | 1480 | 0.27 | 1451 | 0.276 | 107.7911602 | 0.012849134 | 109.4341808 | 0.321544644 | 107.6143516 | 0.034557207 | 107.2828096 | 0.092636994 | 108.6126705 | 0.167196889 | 107.4485806 | 0.0635971 | High | High | Low | Low | 1.5 uM |
| 1192 | 0.0839 | 1269 | 0.0788 | 1480 | 0.27 | 1536 | 0.13 | 106.0999694 | -0.097349384 | 117.5884635 | -0.033861407 | 107.6143516 | 0.034557207 | 113.5674677 | -0.076128861 | 111.8442165 | -0.065605396 | 110.5909096 | -0.020785827 | High | High | Low | Low | 500 nM |
| 1241 | 0 | 1168 | 0.171 | 1489 | 0.269 | 1469 | 0.136 | 110.4614614 | -0.211352536 | 108.2295709 | 0.092074173 | 108.2687632 | 0.033407336 | 108.6136784 | -0.069193278 | 109.3455161 | -0.059639182 | 108.4412208 | -0.017892971 | High | High | Low | Low | 10 mM |
| 1139 | 0.0878 | 1049 | 0 | 1346 | 0.297 | 1327 | 0.226 | 101.3824372 | -0.092050072 | 97.2027567 | -0.141493985 | 97.87089005 | 0.065603714 | 98.11460259 | 0.034840468 | 99.29259695 | -0.116772029 | 97.99274632 | 0.050222091 | High | High | Low | Low | 3.333 mM |
| 1189 | 0.0841 | 1149 | 0.087 | 1470 | 0.34 | 1403 | 0.214 | 105.8329393 | -0.097077625 | 106.4689871 | -0.022661063 | 106.8872276 | 0.115048152 | 103.7338262 | 0.020969302 | 106.1509632 | -0.059869344 | 105.3105269 | 0.068008727 | High | High | Low | Low | 1.111 mM |
| 1239 | 0 | 1133 | 0.265 | 1476 | 0.203 | 1391 | 0.431 | 110.2834414 | -0.211352536 | 104.9863902 | 0.220468365 | 107.323502 | -0.042484127 | 102.8465804 | 0.271806223 | 107.6349158 | 0.004557914 | 105.0850412 | 0.114661048 | High | High | Low | Low | 370 uM |
| Fluorescence Polarization | Total Intensity | Z-score_FP | Z-score_Total Intensity | % Elongation_FP | % Elongation_Total Intensity | Fluorogenic |
|---|---|---|---|---|---|---|
| 256.7 | 36080052 | -0.1 | 0.3 | 102 | 113 | |
| 255.7 | 36170657 | -0.3 | 0.3 | 101 | 113 | |
| 256.9 | 35420114 | -0.1 | -0.3 | 102 | 107 | |
| 255.2 | 35741699 | -0.4 | 0 | 100 | 110 | |
| 257.5 | 35227125 | 0 | -0.5 | 103 | 105 | |
| 256.6 | 35252352 | -0.2 | -0.5 | 102 | 105 | |
| 259 | 35849065 | 0.3 | 0.1 | 105 | 111 | |
| 261 | 35903311 | 0.7 | 0.1 | 107 | 111 | |
| 259.7 | 35971169 | 0.5 | 0.2 | 106 | 112 | |
| 260.5 | 36236704 | 0.6 | 0.4 | 107 | 114 | |
| 257.4 | 36144089 | 0 | 0.3 | 103 | 113 | |
| 260.7 | 36158205 | 0.6 | 0.3 | 107 | 113 | |
| 260.4 | 36254981 | 0.6 | 0.4 | 107 | 114 | |
| 261.8 | 36799901 | 0.9 | 0.9 | 108 | 119 | |
| 257.7 | 36498125 | 0.1 | 0.6 | 103 | 116 | |
| 255.9 | 35232080 | -0.3 | -0.5 | 101 | 105 | |
| 256.8 | 35726936 | -0.1 | 0 | 102 | 110 | |
| 257.9 | 36378227 | 0.1 | 0.5 | 104 | 115 | |
| 258.7 | 36309511 | 0.3 | 0.5 | 105 | 115 | |
| 256.8 | 36098037 | -0.1 | 0.3 | 102 | 113 |
| Percentage of inhibition | BIOACTIVITY_PHENOTYPE |
|---|---|
| -7.36402 | |
| -2.25941 | |
| 0.502092 | |
| -6.10879 | |
| 1.841 | |
| -10.795 | |
| -25.3556 | |
| -10.6276 | |
| -7.61506 | |
| 10.0833 | |
| -2.91667 | |
| 2.66667 | |
| -18.75 | |
| -18.3333 | |
| -19.4167 | |
| -24.5 | |
| 3.16667 | |
| 13.5 | |
| 5.47112 | |
| 10.9422 |
| Standard Type | Activity Comment |
|---|---|
| Anticonvulsant activity | Virtual activity |
| Anticonvulsant activity | Virtual activity |
| Anticonvulsant activity | Virtual activity |
| Anticonvulsant activity | Virtual activity |
| Anticonvulsant activity | Virtual activity |
| Anticonvulsant activity | Virtual activity |
| Anticonvulsant activity | Virtual activity |
| Anticonvulsant activity | Virtual activity |
| Anticonvulsant activity | Virtual activity |
| Anticonvulsant activity | Virtual activity |
| Anticonvulsant activity | Virtual activity |
| Anticonvulsant activity | Virtual activity |
| Anticonvulsant activity | Virtual activity |
| Anticonvulsant activity | Virtual activity |
| Anticonvulsant activity | Virtual activity |
| Anticonvulsant activity | Virtual activity |
| Anticonvulsant activity | Virtual activity |
| Anticonvulsant activity | Virtual activity |
| Anticonvulsant activity | Virtual activity |
| Anticonvulsant activity | Virtual activity |
| Phenotype | Potency | Efficacy | Analysis Comment | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.00366 uM | Activity at 0.018 uM | Activity at 0.091 uM | Activity at 0.229 uM | Activity at 0.457 uM | Activity at 0.575 uM | Activity at 0.943 uM | Activity at 1.600 uM | Activity at 2.289 uM | Activity at 3.140 uM | Activity at 4.718 uM | Activity at 9.139 uM | Activity at 11.40 uM | Activity at 21.05 uM | Activity at 28.60 uM | Activity at 57.06 uM | Activity at 80.69 uM | Activity at 114.0 uM | Activity at 162.0 uM | Activity at 229.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 4 | 0 0 0 0 0 | -0.226 | 6.4746 | 0.9204 | -0.5372 | 0.8592 | -0.226 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | 12.8562 | -1.8356 | -5.6647 | -0.017 | -0.5558 | 12.8562 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | 12.5006 | -1.9757 | -2.1008 | -2.1909 | -3.9301 | 12.5006 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | 2.0579 | -4.4772 | -3.3361 | -4.7626 | -5.2019 | 2.0579 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | 4.1372 | -0.9471 | -3.1539 | -7.212 | -6.4925 | 4.1372 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||
| Inactive | 4 | -2.6054 | -9.932 | -7.5404 | -0.2177 | -8.4216 | -2.6054 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 1 | -3.0398 | -2.9765 | -4.4925 | -0.7002 | 2.9936 | -3.0398 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -3.074 | 3.888 | 1.2985 | 0.6146 | -0.3069 | -3.074 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -9.7692 | -4.4338 | -3.3244 | -6.5932 | -4.4097 | -9.7692 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 0 | 6.2922 | -3.5076 | -1.5083 | 2.7239 | 7.2009 | 5.3756 | 6.2922 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||
| Inactive | 4 | -0.2544 | -0.2233 | -1.1943 | -3.5748 | -3.6048 | -2.2861 | -0.2544 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -1.5988 | 14.2358 | 2.588 | 5.3038 | 2.9078 | -1.5988 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||
| Inactive | 4 | -3.7605 | -2.861 | 1.5078 | 2.0007 | 0.948 | -2.2965 | -3.7605 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||
| Inactive | 4 | 5.982 | 5.5678 | 4.2928 | 9.2904 | 6.0688 | 4.4563 | 5.982 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 0 | 6.8353 | 2.5813 | -3.1437 | -3.6312 | 2.5513 | 11.3967 | 6.8353 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 0 | -2.3409 | 7.0392 | -3.5682 | -1.7692 | 5.9909 | -2.9248 | -2.3409 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 1 | 0.4459 | -0.2996 | -0.8455 | -0.1901 | 8.987 | 0.4459 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||
| Inactive | 4 | 1.1584 | 5.9201 | 4.3416 | -2.2202 | -2.3243 | 6.6441 | 1.1584 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||
| Inactive | 4 | 6.7843 | 4.8805 | 4.8824 | 3.991 | 4.4147 | 6.7843 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -15.7664 | 1.54 | 2.1877 | 3.2591 | 9.3946 | -15.7664 | QC'd by "Asinex Ltd." |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.00457 uM | Activity at 0.023 uM | Activity at 0.029 uM | Activity at 0.047 uM | Activity at 0.084 uM | Activity at 0.127 uM | Activity at 0.212 uM | Activity at 0.303 uM | Activity at 0.463 uM | Activity at 0.774 uM | Activity at 1.183 uM | Activity at 2.152 uM | Activity at 2.856 uM | Activity at 4.631 uM | Activity at 6.701 uM | Activity at 11.26 uM | Activity at 16.91 uM | Activity at 27.01 uM | Activity at 39.83 uM | Activity at 57.93 uM | Activity at 97.38 uM | Activity at 146.4 uM | Activity at 210.0 uM | Activity at 304.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 4 | -6.0625 | -2.3623 | -0.2802 | -5.2775 | -6.0625 | QC'd by Evotec (US) Inc. | ||||||||||||||||||||||||||||||
| Inhibitor | 35.4813 | 40.7736 | 10 | Single point of activity | -4.45 | 2.4064 | 0.933 | -44.7736 | -4 | -3 | 0 0 0 0 | -35.0558 | 0 | -9.6533 | -5.4245 | -35.0558 | QC'd by Evotec (US) Inc. | |||||||||||||||||||||
| Inactive | 0 | -5.85 | 3.9295 | 0.9968 | -13.4932 | 3 | 4 | 0 0 0 0 | -13.1541 | 2.8182 | -11.1738 | -14.161 | -13.1541 | QC'd by UrkORgSynthesis Ltd | ||||||||||||||||||||||||
| Inactive | 0 | -5.1 | 4.9549 | 0.8892 | 13.5 | -3.5623 | 4 | 0 0 0 1 | -8.0174 | -0.4429 | -6.3019 | 11.0739 | -8.0174 | QC'd by Evotec (US) Inc. | ||||||||||||||||||||||||
| Inactive | 0 | 4 | -15.8272 | -9.3466 | -13.7699 | -18.4456 | -15.8272 | QC'd by Evotec (US) Inc. | ||||||||||||||||||||||||||||||
| Inactive | 0 | -5.7 | 2.4064 | 0.8108 | -13.0434 | 0.4341 | 4 | 0 0 0 0 | -9.5936 | -0.0549 | -7.5602 | -16.7029 | -9.5936 | QC'd by Evotec (US) Inc. | ||||||||||||||||||||||||
| Inactive | 0 | 4 | -11.635 | -18.2363 | -13.8009 | -16.9167 | -11.635 | QC'd by Evotec (US) Inc. | ||||||||||||||||||||||||||||||
| Inactive | 0 | 4 | -12.2857 | -9.6332 | -6.6135 | -15.2325 | -12.2857 | QC'd by Evotec (US) Inc. | ||||||||||||||||||||||||||||||
| Activator | 14.1254 | 48.5674 | 0 | Single point of activity | -4.85 | 1.2221 | 0.9975 | 36.9973 | -11.5701 | 3 | 0 0 0 0 | 30.2349 | -11.1897 | -5.7724 | 8.6511 | 30.2349 | QC'd by Evotec (US) Inc. | |||||||||||||||||||||
| Inactive | 0 | -6.2 | 4.9549 | 0.6966 | 2 | -9.5969 | 4 | 0 0 0 1 | -6.1109 | -7.5807 | 5.9101 | -1.5457 | -6.1109 | QC'd by Evotec (US) Inc. | ||||||||||||||||||||||||
| Inactive | 0 | -5.85 | 3.132 | 0.9409 | -21.457 | 7.5 | 4 | 0 0 0 0 | -17.551 | 6.6865 | -16.2327 | -25.7975 | -17.551 | QC'd by ChemBridge | ||||||||||||||||||||||||
| Inactive | 0 | 4 | -8.9062 | -10.0321 | -8.4923 | -13.3892 | -8.9062 | QC'd by Enamine | ||||||||||||||||||||||||||||||
| Inactive | 0 | -4.4 | 4.9549 | 0.6263 | 7.8678 | 51.4183 | 4 | 0 0 0 0 | 13.9623 | 31.0426 | 59.7813 | 63.0809 | 13.9623 | QC'd by Asinex Ltd. | ||||||||||||||||||||||||
| Inhibitor | 19.9526 | 38.6125 | 10 | Single point of activity | -4.7 | 2.3332 | 0.9982 | -39.7401 | -1.1275 | -3 | 0 0 0 0 | -36.5455 | -1.9894 | -0.5229 | -9.5594 | -36.5455 | QC'd by Evotec (US) Inc. | |||||||||||||||||||||
| Inactive | 0 | -6.2 | 4.9549 | 0.9465 | -11.4918 | 22 | 4 | 0 0 0 0 | -6.9123 | 16.7569 | -14.5765 | -13.2401 | -6.9123 | QC'd by ChemBridge | ||||||||||||||||||||||||
| Inactive | 0 | 4 | -15.3605 | -14.6287 | -17.6489 | -22.4317 | -15.3605 | QC'd by Evotec (US) Inc. | ||||||||||||||||||||||||||||||
| Inactive | 0 | -5.5 | 4.5045 | 0.9992 | -8.294 | -20.1637 | 4 | 0 0 0 1 | -21.4275 | -20.1364 | -17.9575 | -8.5783 | -21.4275 | QC'd by Evotec (US) Inc. | ||||||||||||||||||||||||
| Inactive | 0 | 4 | -15.0697 | -19.7843 | -18.2327 | -16.8712 | -15.0697 | QC'd by Evotec (US) Inc. | ||||||||||||||||||||||||||||||
| Inactive | 0 | -5.5 | 3.99 | 0.9996 | -14.5384 | 2 | 4 | 0 0 0 1 | -1.5533 | 1.9923 | -1.6259 | -14.1987 | -1.5533 | QC'd by Asinex Ltd. | ||||||||||||||||||||||||
| Inactive | 0 | -4.85 | 3.9295 | 0.9256 | 2.5 | -10.3046 | 4 | 0 0 0 0 | 2.6164 | -8.1304 | -12.3372 | -6.3737 | 2.6164 | QC'd by Evotec (US) Inc. |
| EXPID | PREFIX | CONCENTRATION_UNIT | CONCENTRATION | PANELNBR | CELLNBR | PANELNAME | CELLNAME | PANELCODE | M_GIPRCNT | N_GIPRCNT | STDDEV_GIPRCNT | EXP_COUNT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2106OS49 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 88.231 | 1 | 0 | 1 |
| 2106OS49 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 87.1119 | 1 | 0 | 1 |
| 2106OS49 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 14.4371 | 1 | 0 | 1 |
| 2106OS49 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 89.7113 | 1 | 0 | 1 |
| 2106OS49 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 97.2463 | 1 | 0 | 1 |
| 2106OS49 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 90.0129 | 1 | 0 | 1 |
| 2106OS49 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 85.7031 | 1 | 0 | 1 |
| 2106OS49 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 30.8539 | 1 | 0 | 1 |
| 2106OS49 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 14.2896 | 1 | 0 | 1 |
| 2106OS49 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 85.8526 | 1 | 0 | 1 |
| 2106OS49 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 83.1036 | 1 | 0 | 1 |
| 2106OS49 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 84.2194 | 1 | 0 | 1 |
| 2106OS49 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 89.3237 | 1 | 0 | 1 |
| 2106OS49 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 85.6034 | 1 | 0 | 1 |
| 2106OS49 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 89.6643 | 1 | 0 | 1 |
| 2106OS52 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 91.2503 | 1 | 0 | 1 |
| 2106OS52 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 94.8714 | 1 | 0 | 1 |
| 2106OS52 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 93.7372 | 1 | 0 | 1 |
| 2106OS52 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 112.6132 | 1 | 0 | 1 |
| 2106OS52 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 73.375 | 1 | 0 | 1 |